https://cmr.2.broadcastmed.net/ 2018-04-05T23:50:52+0000 weekly 1 https://cmr.2.broadcastmed.net/videos/dual-ketone-and-glucose-cgm-monitoring-for-integration-with-insulin-delivery/pump-systems-br-sub-interactive-case-based-clinic-with-cgm-experts-board/sub 2024-03-06T00:18:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc5 2019-02-12T01:25:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/complex-patients-who-have-been-on-various-insulin-formulations-who-present-with-specific-clinical-profiles-safety-needs-and-glycemic-dysregulation-issues-that-make-them-candidates-for-a-long-acting-physiologic-insulin-and-for-switching 2018-11-15T06:46:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-guidelines-and-real-world-trials-to-guide-practical-aspects-of-diabetes-care-in-the-managed-care/hmo-setting 2021-07-30T06:22:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-case-management-sessions-putting-cgm-into-practice-in-the-real-world-br-sub-using-new-glycemic-metric-destinations-to-move-beyond-hba1c/sub 2023-06-22T21:31:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-sensor-based-cgm-in-the-diabetes-specialist-setting-br-sub-identifying-new-glycemic-metric-destinations-beyond-hba1c/sub 2023-10-11T17:15:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-landmark-clinical-trials-in-sensor-based-technology-to-t1-and-t2-diabetes-care 2019-10-09T21:59:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-critical-fundamentals-of-sensor-based-cgm-a-primary-provider-s-perspective 2022-05-19T21:48:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-case-based-clinic-with-cgm-experts-board-data-interventions-patient-care-optimization-br-sub-early-application-of-cgm-to-proactively-manage-type-2-diabetes-in-the-real-world/sub 2024-06-19T02:16:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/rationale-for-flash-glucose-monitoring-across-the-full-spectrum-of-diabetes-care-br-sub-focus-on-optimizing-clinical-end-points-in-type-2-diabetes/sub 2022-09-15T19:32:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-interactive-case-management-sessions-with-the-faculty-clinical-decision-making-using-sensor-based-glucose-monitoring-technology 2019-03-21T23:48:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc3 2018-12-27T21:00:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/physiologic-basal-insulin-interactive-ars-case-management-session-3-vivian-fonseca-md-frcp-program-chair 2018-04-18T23:17:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-study-3 2018-11-21T02:37:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-conversations-on-the-use-of-technology-in-the-primary-care-setting 2022-04-01T02:14:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management 2018-12-07T19:44:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer4 2019-02-08T00:03:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-cgm-for-identifying-new-glycemic-metric-destinations-beyond-ha1c 2024-05-14T19:09:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/established-strategies-and-evolving-approaches-for-ncfbe 2022-02-22T21:45:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/fundamentals-of-sensor-based-cgm-the-nurse-practitioner-s-perspective 2022-06-21T20:35:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-case-management-and-dialogue-sessions-focused-on-identifying-real-world-patients-with-cscc-who-are-appropriate-candidates-for-pd-1-checkpoint-inhibitor 2019-03-26T18:57:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/incorporating-cgm-based-glucose-pattern-insight-reports-gpir-and-treatment-prompts-in-type-2-diabetes-br-sub-focus-on-refining-and-simplifying-clinical-glycemic-control-for-the-family-medicine-specialist/sub 2022-09-13T00:01:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-flash-based-cgm-to-the-front-lines-of-diabetes-care-in-the-real-world-patient-case-management-session 2021-09-27T21:17:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-landmark-trials-and-meta-analyses-trials-in-cgm-to-the-front-lines-of-diabetes-care-focus-on-the-role-of-sensor-based-technology-to-improve-time-in-range-and-interpretation-of-ambulatory-glucose-profiles 2020-03-13T00:28:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer3 2018-12-27T21:00:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-clinical-suspicion-and-co-morbid-risk-factors-to-diagnostic-confirmation-of-mac-lung-disease1 2021-11-22T22:59:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/is-cgm-the-key-to-managing-healthcare-utilization-in-persons-with-diabetes-br-sub-a-technology-based-approach-to-improving-outcomes-and-reducing-hospitalization/sub 2024-06-19T02:15:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/how-to-best-incorporate-cgm-into-the-managed-care-pharmacy-practice 2021-10-21T00:27:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-sensor-based-technology-to-optimize-blood-glucose-time-in-range-tir-health-metrics-across-the-comprehensive-spectrum-of-diabetes-care-establishing-a-new-guideline-and-evidence-based-standard-of-care-for-persons-with-diabetes 2020-09-18T04:00:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-basal-insulins-are-not-created-equal-comparative-pk/pd-efficacy-side-effect-hypoglycemia-and-safety-profiles-for-established-and-new-longer-acting-basal-insulins-a-translational-roadmap-for-the-diabetes-specialist 2018-11-21T23:15:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/landmark-trials-supporting-pd-1-checkpoint-inhibition-for-advanced-cscc 2019-01-08T18:52:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/getting-real-world-and-hands-on-in-diabetes-practice-results-of-cv-outcome-trials-and-year-2017-acc-ecdp-guidelines-applied-to-the-front-lines-of-diabetes-care 2018-11-15T05:49:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-new-evolving-standard-for-optimizing-quality-of-diabetes-care-br-sub-how-do-ambulatory-glucose-profiles-agp-improve-diabetes-management-in-persons-with-t2d/sub 2023-09-28T22:26:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc2 2018-12-07T19:52:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/advancing-the-treatment-frontiers-for-metastatic-pancreatic-adenocarcinoma-pdac-and-pnet 2018-11-21T02:36:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/improvements-in-health-outcomes-associated-with-the-use-of-cgm-health-economic-data-hospitalization-rates-and-clinical-outcomes 2020-06-08T23:08:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-sensor-based-cgm-in-the-diabetes-specialist-setting-identifying-new-glycemic-metric-destinations-beyond-ha1c 2023-06-22T21:29:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-cgm-based-best-practice/best-outcome-roadmap-for-persons-across-the-full-spectrum-of-diabetes-br-sub-which-patients-at-what-point-in-their-clinical-course-for-how-long-with-what-goals/sub 2022-04-26T02:58:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/post-program-confirmation-of-program-success 2019-01-07T20:10:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/basal-insulin-as-a-foundational-strategy-in-t2d-vivian-fonseca-md-frcp-program-chair 2018-09-29T00:55:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/maximizing-patient-engagement-and-satisfaction-with-sensor-based-glucose-monitoring-br-sub-new-real-world-data-confirming-patient-centric-preferences-for-cgm-based-care-in-the-primary-provider-setting/sub1 2023-06-23T03:03:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-the-retina-specialist-for-optimizing-management-and-preventing-vision-loss-in-age-related-macular-degeneration-amd-and-diabetic-macular-edema-dme 2018-11-21T00:55:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-current-and-future-roadmap-to-optimizing-basal-insulin-based-glycemic-control-in-t2d-vivian-fonseca-md-frcp-program-chair 2018-04-18T23:18:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-sensor-based-cgm-for-managing-type-2-diabetes-the-rationale-for-cgm-directed-therapeutic-interventions-br-sub-establishing-a-best-practice-best-outcomes-standard-of-care-for-persons-with-diabetes/sub 2022-05-27T21:50:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/glucose-control-quality-of-life-and-health-delivery-benefits-of-deploying-flash-based-cgm-across-the-diabetes-population 2021-09-27T21:16:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-cgm-for-identifying-new-glycemic-metric-destinations-beyond-hba1c-a-br-sub-clinical-success-roadmap-for-improving-outcomes-across-the-type-2-and-type-i-spectrum-of-care/sub 2024-02-29T01:11:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/which-patients-with-advanced-cscc-will-likely-benefit-most-from-pd1-checkpoint-inhibition1 2018-12-07T19:45:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-based-practical-aspects-of-establishing-and-deploying-cgm-at-the-front-lines-of-care-for-t2d-br-sub-barriers-solutions-and-patient-identification-in-the-family-practice/sub 2022-09-13T00:01:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session3 2019-02-12T01:26:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-epidemiology-disease-burden-and-demographics-of-diabetes-associated-and-age-related-macular-degenerative-disease 2018-11-21T00:36:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-step-by-step-approach-to-launching-and-maintaining-a-cgm/agp-based-management-program-in-the-primary-care-setting 2022-03-16T22:40:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diabetes-management-case-study-5 2018-11-21T23:29:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-and-foundational-role-of-personalized-ha1c-to-optimize-management-of-diabetes 2019-07-10T20:07:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-interactive-case-management-sessions-utilizing-audience-response-system 2019-10-10T18:12:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diagnosis-evaluation-and-treatment-of-bronchiectasis-evolving-strategies-for-managing-exacerbations 2023-03-31T17:25:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management3 2018-12-27T21:01:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-and-microbiologic-confirmation-of-mac-lung-disease-br-sub-guiding-antibiotic-selection-and-intensity-based-on-systematic-microbiological-testing-and-risk-stratification/sub 2022-09-01T21:23:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc2 2018-12-07T19:52:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/novel-mechanisms-and-advancing-paradigms-for-ldl-reduction 2018-11-15T04:05:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-guidelines-and-meta-analysis-trials-to-guide-practical-aspects-of-diabetes-care-using-sensor-based-glucose-monitoring-to-improve-time-in-range-tir-for-persons-with-diabetes-on-non-insulin-regimens 2020-09-18T16:50:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-updated-ada/easd-guidelines-to-a-high-risk-vulnerable-patient-with-t2d-who-has-not-achieved-target-ha1c-levels-after-metformin-and-an-sglt-2-inhibitor-program-co-chairs-and-distinguished-faculty 2018-11-15T06:39:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session1 2018-11-15T09:33:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-mediated-improvements-in-ha1c-and-regimen-adherence-in-the-setting-of-glp-1-agonists 2025-03-17T19:16:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc4 2019-02-08T00:03:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mechanistic-and-guidelines-sanctioned-rationale-for-optimizing-ha1c-target-goal-attainment-with-physiologic-long-acting-basal-insulin-vivian-a-fonseca-md-program-co-chair 2018-11-15T06:38:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-qanda-session-and-special-hot-topics-in-t2d-session-faculty-panel 2018-11-21T22:48:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-study-4 2018-11-21T02:38:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-sensor-based-cgm-in-the-primary-provider-setting-new-guidelines-provide-a-roadmap-for-better-readouts-and-better-outcomes 2023-10-24T19:43:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-actionability-of-the-ambulatory-glucose-profiles-agp-for-guiding-therapeutic-decisions-on-t2d 2024-06-22T17:41:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathophysiology-risk-factors-profiles-and-clinical-manifestations-of-age-related-macular-generation-amd-and-diabetic-edema-dme1 2018-11-21T02:32:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-ntm-patients-are-not-created-equal-br-sub-focus-on-prompt-intervention-individualized-management-and-risk-severity-directed-treatment-for-refractory-mac-lung-disease/sub 2023-09-06T21:06:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session 2018-11-15T04:08:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-power-of-cgm-as-a-lifestyle-intervention-platform-br-sub-interactive-case-study-deploying-the-agp-report-to-engage-and-motivate/sub 2024-09-05T18:50:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-emerging-foundational-role-of-sensor-based-cgm-for-managing-diabetes-in-the-managed-care-pharmacy-br-sub-the-managed-care-pharmacist-s-role-in-improving-patient-outcomes-by-deploying-cgm-based-care/sub 2022-03-22T18:22:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-strategies-for-ldl-mediated-cv-risk-reduction-in-vulnerable-diabetic-patients 2018-11-15T04:07:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-for-improving-residual-cvd-risk-reduction-in-diabetic-patients-what-unmet-needs-still-exist-among-high-risk-patients-across-the-diabetes-continuum-of-care-what-new-outcome-substantiated-therapies-are-in-our-toolkit 2018-11-15T05:43:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-type-2-diabetes-focus-on-physiologic-long-acting-insulin-based-management-of-t2d 2018-11-15T06:47:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-current-therapeutic-landscape-for-cv-risk-reduction-in-patients-with-hypercholesterolemia 2018-11-15T04:02:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-and-prospective-trials-supporting-cgm-as-a-foundational-approach-to-management-of-diabetes 2021-09-27T21:15:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-glycemic-control-while-mitigating-hypoglycemic-risk-in-challenging-patients-with-t2d1 2018-11-21T21:45:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-sensor-based-glucose-monitoring-and-telemedicine-to-optimize-real-world-impact-and-diabetes-management-in-the-age-of-covid-19-what-have-the-studies-taught-us-how-do-we-apply-them-to-diabetes-practice-now 2020-09-18T04:00:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/maximizing-patient-engagement-satisfaction-and-clinical-outcomes-with-sensor-based-glucose-monitoring-in-type-2-diabetes 2023-06-22T21:32:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/maximizing-patient-engagement-satisfaction-and-clinical-outcomes-with-sensor-based-glucose-monitoring-in-type-2-diabetes-br-sub-new-real-world-data-confirming-patient-and-physician-centric-preferences-for-cgm-based/sub 2023-09-28T23:32:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/ada-2020-key-abstracts-and-posters-in-continuous-glucose-monitoring 2020-06-05T23:41:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-actionability-of-glucose-pattern-insight-report-gpir-and-the-ambulatory-glucose-profiles-agp-for-guiding-therapeutic-decisions-on-t2d 2024-05-14T19:22:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-hba1cs-are-not-created-equal-patient-management-case-studies-br-sub-using-individualized-agp-reports-and-glycemic-metrics-to-move-beyond-ha1c-to-optimize-health-outcomes-in-diabetes/sub 2023-02-20T19:38:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/conclusions-the-foundational-role-of-pd-1-checkpoint-inhibition-in-cscc 2019-01-07T20:06:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4994 2018-04-13T18:29:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-science-guidelines-and-landmark-trial-based-evidence-to-the-front-lines-of-pancreatic-cancer-practice 2018-11-21T02:36:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-sensor-based-glucose-monitoring-technology-in-the-managed-care/hmo-setting 2021-07-30T06:21:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/ncfbe-clinical-evaluation-and-diagnosis-disease-management-overview-risk-stratification-and-the-role-of-dpp-1-inhibition-in-managing-exacerbations 2022-11-10T03:04:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/novel-therapeutic-advances-in-non-cystic-fibrosis-bronchiectasis-ncfbe-br-sub-new-approaches-for-minimizing-exacerbations/sub 2022-09-02T22:38:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-for-individualized-care-in-persons-with-ntm-lung-disease-and-limited-options-br-sub-when-and-how-to-intensify-antimicrobial-therapies-based-on-clinical-presentation-and-microbial-testing/sub 2025-03-17T19:15:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/improving-overall-resource-utilization-reducing-costs-and-complications-and-improving-glycemic-metrics-with-sensor-based-cgm 2022-04-19T05:07:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/inhaled-antimicrobial-therapy-for-mac-lung-disease-completing-the-journey-from-diagnosis-to-cure 2023-06-21T22:42:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-technologies-and-device-improvements-in-cgm-focus-on-glucose-pattern-insight-reports-gpir-to-efficiently-guide-care-prevent-hypoglycemia-and-modify-therapy-in-persons-with-diabetes 2023-10-11T22:16:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-sensor-based-glucose-monitoring-cgm-to-reduce-cost-intensive-adverse-drug-events-associated-with-diabetes-treatment 2021-07-30T06:21:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/foundational-pathobiological-and-novel-therapeutic-advances-in-non-cystic-fibrosis-bronchiectasis-ncfbe 2022-02-12T06:32:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc7 2019-03-26T18:57:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-profound-positive-impact-of-cgm-on-glycemic-control-and-patient-engagement 2025-03-17T19:17:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer6 2019-02-12T01:27:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-interactive-case-management-sessions-with-the-faculty-clinical-decision-making-using-sensor-based-glucose-monitoring-technology-across-the-full-spectrum-of-diabetes-care 2020-03-13T00:32:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc1 2018-12-07T19:44:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-best-practice/best-outcome-roadmap-for-type-2-diabetes-cgm-for-which-patients-at-what-point-in-their-clinical-course-for-how-long-with-what-goals 2022-05-27T21:52:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-data-and-evidence-supporting-the-use-of-sensor-based-continuous-glucose-monitoring-cgm 2020-06-08T23:08:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-as-a-foundational-strategy-for-reducing-complications-of-diabetes-br-sub-deploying-sensor-based-cgm-for-overall-cardiovascular-risk-reduction-in-persons-with-type-2-diabetes/sub 2022-03-22T18:28:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-management-of-mac-lung-disease-with-guideline-based-therapy 2021-09-01T00:42:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-glycemic-control-while-mitigating-hypoglycemic-risk-in-t2d-pablo-f-mora-md-face-cde 2018-04-18T23:22:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-ats/idsa/ers/escmid-guideline-directed-management-pathways-and-clinical-trial-results-in-ntm-pd-to-the-front-lines-of-patient-care-br-sub-high-risk-patients-and-clinical-findings-predictive-of-refractory-mac-pulmonary-disease 2023-09-07T20:35:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-for-foundational-management-of-diabetes-precision-readouts-time-in-range-tir-glucose-variability-and-agp-report-interpretation-to-optimize-comprehensive-glycemic-metrics-in-type-2-diabetes 2023-02-17T22:01:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-landmark-trials-and-meta-analyses-trials-to-the-front-lines-of-diabetes-care 2019-03-21T23:48:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/selection-and-timing-of-initial-foundational-therapy-for-gastrointestinal-neuroendocrine-tumors-nets-critical-issues-for-treatment-initiation-and-subsequent-management-of-the-complex-patient-what-does-the-evidence-show 2018-11-15T08:22:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/incorporating-cgm-based-glucose-pattern-insight-reports-gpir-and-treatment-prompts-in-type-2-diabetes-br-sub-focus-on-refining-and-simplifying-clinical-decision-making-based-on-cgm/sub 2022-05-27T21:52:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/scientific-logic/technology-presentation-for-dota/dotr 2019-09-14T00:22:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/how-do-ambulatory-glucose-profiles-agp-and-glucose-profile-insight-reports-gpir-improve-diabetes-management-clinical-outcomes-and-provider-interventions-in-persons-with-t2d1 2023-10-24T19:44:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-landscape-of-sensor-based-technology-for-optimizing-clinical-outcomes-across-the-comprehensive-spectrum-of-type-1-and-type-2-diabetes-care 2019-03-21T23:49:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/science-and-evidence-into-gi-oncology-net-focused-practice 2018-11-15T08:28:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/an-evolving-standard-for-optimizing-quality-of-diabetes-care 2023-05-19T22:06:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-cgm-based-glycemic-management-in-the-age-of-telemedicine-lessons-learned-during-the-global-covid-19-pandemic 2022-04-27T17:14:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/beyond-the-statin-centric-paradigm-for-cv-risk-reduction 2018-11-15T04:03:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/program-chair-s-summary-vision-statement-overcoming-institutional-cost-and-clinical-inertia-barriers-to-deployment-of-non-statin-therapies-for-optimizing-cv-outcomes-in-diabetes 2018-11-15T05:50:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-current-landscape-of-sensor-based-continuous-glucose-monitoring 2019-10-10T18:11:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-to-screen-and-intervene-in-the-optometry-setting-to-prevent-blindness-under-utilization-of-screening-dilated-eye-exams-and-technologies-across-the-continuum-of-macular-degenerative-conditions 2018-11-21T01:59:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/using-cgm-based-glycemic-management-and-agp-readouts-to-improve-diabetes-management-and-outcomes-for-persons-with-t2d-in-the-primary-care-setting 2022-08-09T00:10:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diabetes-management-case-study-3 2018-11-21T23:24:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-sensor-based-glucose-monitoring-technology-how-should-clinicians-and-patients-collaborate-to-improve-clinical-outcomes-and-patient-care 2019-03-21T23:47:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/insulin-differentiation-and-clinical-decision-making-comparative-pk/pd-efficacy-side-effect-hypoglycemia-and-safety-profiles-for-physiologic-long-acting-basal-insulins-an-insulin-centric-roadmap-for-the-diabetes-specialist 2018-11-15T06:41:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/landmark-evidence-for-deploying-sensor-based-cgm-technology-in-diabetes 2019-07-10T20:09:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-real-world-case-based-context-for-deploying-sensor-based-cgm-in-the-managed-care-pharmacy 2021-10-21T00:22:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-rationale-and-evidence-for-pd-1-checkpoint-inhibition-in-advanced-cscc 2019-03-26T18:58:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-case-management-ars-session 2019-01-07T20:02:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-decision-making-for-metastatic-pancreatic-adenocarcinoma1 2018-11-21T02:34:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-burden-and-unmet-therapeutic-needs-in-patients-with-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc 2019-03-26T22:45:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session2 2018-11-21T02:43:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/fundamentals-of-sensor-based-cgm-the-family-physician-s-perspective 2022-09-12T23:59:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/chair-s-vision-statement-and-data-to-clinic-translational-summary1 2019-02-08T00:03:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-cancer 2019-02-01T01:49:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session-faculty-panel 2018-12-27T21:02:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-aspects-of-starting-cgm-in-your-primary-care-practice 2023-01-05T00:15:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-strategies-for-incorporating-cgm-into-practice-br-sub-how-can-managed-care-physicians-and-pharmacists-establish-sensor-based-cgm-in-their-managed-care-practice-setting/sub 2022-11-22T23:06:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/novel-theranostics-focused-strategies-for-optimizing-deployment-of-ssas-in-patients-with-advanced-and-metastatic-gep-nets 2018-11-15T09:27:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/risk-stratification-and-therapeutic-targeting-for-ncfbe-br-guideline-based-strategies-and-emerging-novel-therapies 2022-03-22T03:00:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/maximizing-patient-engagement-and-satisfaction-with-sensor-based-glucose-monitoring-br-sub-new-real-world-data-confirming-patient-centric-preferences-for-cgm-based-care-in-the-primary-provider-setting/sub2 2024-02-29T01:10:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-technological-advances-in-cgm-to-move-beyond-hba1c-in-older-persons-with-t2d1 2024-06-22T17:41:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-colorectal-cancer-and-biliary-tract-cancer 2019-10-08T00:55:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc4 2019-02-12T01:25:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-case-management-evaluating-and-managing-patients-with-advanced-mac-lung-disease/refractory-features 2021-09-01T00:40:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-technology-guideline-endorsed-screening-protocols-and-methodologies-to-optimize-detection-of-dme-and-amd-in-the-optometry-setting1 2018-11-21T02:36:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/physiologic-long-acting-basal-insulin-interactive-ars-case-mangemement-session-1-pablo-mora-md-msc-face-cde 2018-04-18T23:22:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-evidence-to-optimal-management-of-gep-nets 2018-11-15T09:24:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-technological-advances-in-cgm-to-move-beyond-hba1c-in-older-persons-with-t2d 2024-05-14T19:24:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathophysiology-risk-factors-profiles-and-clinical-manifestations-of-age-related-macular-generation-amd-and-diabetic-edema-dme 2018-11-21T02:00:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-strategies-for-ldl-mediated-cv-risk-reduction-in-high-risk-and-statin-intolerant-patients-requiring-ldl-reduction-clinical-case-study-2 2018-11-15T04:09:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-management-of-mac-lung-disease-with-guideline-based-therapy-br-sub-current-evidence-and-trial-based-recommendations-for-applying-ats/idsa/ers/escmid-treatment-plans-for-ntm-pd/sub 2022-09-01T21:24:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-role-of-sensor-based-cgm-as-a-best-practice-strategy-for-managing-persons-with-type-2-diabetes-on-oral-therapy 2022-04-19T05:07:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-therapeutics-for-extending-progression-free-survival-in-patients-with-gi-nets-focus-on-timing-sequencing-and-regimen-initiation-and-maintenance-for-antiproliferative-ssa-and-chemotherapeutic-interventions 2018-11-15T08:16:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-technological-advances-in-cgm-to-move-beyond-hba1c-in-older-persons-with-t2d-br-sub-interactive-case-based-clinic-with-cgm-experts-board/sub 2024-03-01T19:12:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer1 2019-05-22T23:39:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/moving-beyond-hba1c-optimizing-time-in-range-for-persons-with-type-2-diabetes-br-sub-applying-advances-in-cgm-for-improved-glycemic-management-before-insulin-initiation/sub 2024-06-19T02:16:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-based-strategies-for-incorporating-sensor-based-cgm-across-the-diabetes-spectrum-of-care-br-sub-evidence-for-new-quality-metrics-and-standards-for-diabetes-to-optimize-clinical-outcomes/sub 2023-10-23T21:12:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/sensor-based-glucose-monitoring/real-world-studies-and-applications-for-the-type-1-and-type-2-diabetes-population 2019-10-09T21:54:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/how-do-ambulatory-glucose-profiles-agp-and-glucose-profile-insight-reports-gpir-improve-diabetes-management-clinical-outcomes-and-provider-interventions-in-persons-with-t2d 2023-06-22T20:51:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/antimicrobial-decision-making-in-mac-lung-disease-br-sub-when-prompt-therapy-is-preferred-over-a-watch-and-wait-approach-in-ntm-pulmonary-disease-with-limited-options/sub 2024-09-05T22:15:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/identifying-diabetes-patients-who-are-appropriate-candidates-for-glucose-monitoring-technology-all-devices-are-not-created-equal 2019-10-09T21:53:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/maximizing-patient-engagement-and-satisfaction-with-sensor-based-glucose-monitoring-br-sub-new-real-world-data-confirming-patient-centric-preferences-for-cgm-based-care-in-the-primary-provider-setting/sub 2023-05-19T22:06:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-qanda-session 2018-11-15T05:52:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-basal-insulins-are-not-created-equal-neil-skolnik-md-face 2018-04-18T23:24:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/preventing-inevitable-blindness-in-the-diabetic-patient-focus-on-screening-examinations-detection-risk-stratification-and-prompt-referral-to-retina-specialists-of-individuals-with-diabetic-retinopathy 2021-01-14T02:05:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/which-patients-with-advanced-cscc-will-likely-benefit-most-from-pd1-checkpoint-inhibition2 2018-12-07T19:54:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/how-have-recent-studies-helped-us-identify-persons-with-diabetes-who-are-ideal-candidates-for-sensor-based-cgm 2019-07-10T20:10:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-the-retina-specialist-for-optimizing-management-and-preventing-vision-loss-in-age-related-macular-degeneration-amd-and-diabetic-macular-edema-dme1 2018-11-21T02:38:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/incorporating-cgm-based-glucose-pattern-insight-reports-gpir-and-treatment-prompts-in-type-2-diabetes-br-sub-focus-on-refining-and-simplifying-clinical-glycemic-control-for-the-np/sub 2022-06-21T20:31:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-epidemiology-disease-burden-and-demographics-of-diabetes-associated-and-age-related-macular-degenerative-disease1 2018-11-21T02:54:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/latest-advances-in-pd-1-checkpoint-inhibition-for-cscc 2019-01-08T18:51:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-landscape-of-sensor-based-technology-for-optimizing-clinical-outcomes-across-the-comprehensive-spectrum-of-type-1-and-type-2-diabetes-care1 2020-03-12T23:56:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/what-do-recent-landmark-cardiovascular-outcome-trials-evaluating-pcsk9-inhibition-in-the-diabetic-patient-population-teach-us-how-effective-are-pcsk9-inhibitors-in-the-diabetic-population-overall-how-safe 2018-11-15T05:46:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-qanda-and-discussion-sessions 2018-11-21T00:49:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-evidence-rationale-and-ada-guidelines-for-incorporating-sensor-based-cgm-to-optimize-diabetes-management-in-the-managed-care-setting-br-sub-why-does-cgm-represent-a-new-standard-of-care/sub 2022-03-22T18:26:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/program-summary-and-conclusion-moving-beyond-hba1c 2023-06-22T21:31:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-continuous-glucose-monitoring-in-the-managed-care-pharmacy 2021-10-21T00:20:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-to-minimize-hypoglycemic-risk-in-challenging-patients-with-t2d-who-is-vulnerable-and-why-how-can-physiologic-long-acting-basal-insulin-pablo-f-mora-md-msc-face-cde 2018-11-15T06:37:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/identifying-persons-with-diabetes-who-will-benefit-from-sensor-based-cgm 2021-12-14T04:52:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer5 2019-02-12T01:24:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/balancing-the-safety-efficacy-equation-in-the-older-vulnerable-patient-with-t2d-at-risk-for-nocturnal-hypoglycemia 2018-11-15T06:42:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diagnosis-evaluation-and-treatment-of-bronchiectasis 2022-02-09T20:24:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/focus-on-the-evolving-evidence-based-role-of-novel-therapies-and-technologies-for-prolongation-of-progression-free-survival-in-patients-with-gastrointestinal-nets 2018-11-15T08:26:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-actionability-of-ambulatory-glucose-profiles-agp-for-guiding-therapeutic-decisions-on-t2d-br-sub-interactive-case-based-clinic-with-cgm-experts-board/sub 2024-03-02T02:31:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-patient-management-sessions-putting-cgm-into-practice-in-the-real-world-br-sub-using-individualized-agp/gpir-reports-and-glycemic-metrics-to-move-beyond-hba1c/sub 2023-10-24T19:46:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/selecting-persons-with-diabetes-who-are-eligible-for-cgm-reimbursement-in-managed-care-settings-br-sub-the-role-of-cardiovascular-risk-reduction-as-a-strategy-for-employing-cgm-at-the-front-lines-of-diabetes-and-primary-care/sub 2022-11-22T23:06:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/patient-identification-selection-and-timing-of-antimicrobial-treatment-in-the-context-of-year-2020-ers/ats/escmid/idsa-guideline-based-therapy-for-mac-lung-disease 2021-09-01T00:44:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-patient-management-case-studies-br-sub-using-individualized-agp-reports-and-new-glycemic-metric-destinations-to-move-beyond-hba1c/sub 2023-09-28T17:42:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc3 2018-12-27T21:00:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diabetes-management-case-study-4 2018-11-21T23:26:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/novel-radiotherapeutic-focused-strategies-for-targeting-deployment-of-ssas-in-patients-with-advanced-and-metastatic-gep-nets-the-role-and-rationale-for-use-of-technology-focused-strategies-such-as-prrt-as-part-of-multimodal-management-se 2018-11-15T08:24:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-evidence-based-and-guideline-supported-role-for-nanoliposomal-topoisomerase-inhibitors-in-metastatic-pancreatic-adenocarcinoma1 2018-11-21T02:35:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-strategies-and-practice-advances-for-the-comprehensive-continuum-of-gastrointestinal-neuroendocrine-tumors-nets-what-do-we-know-what-do-we-still-need-to-know 2018-11-15T08:19:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/an-evolving-standard-for-optimizing-quality-of-diabetes-care-how-do-ambulatory-glucose-profiles-agp-and-glucose-profile-insight-reports-gpir-improve-diabetes-management 2023-06-22T21:32:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-strategies-guidelines-and-therapeutic-advances-for-the-comprehensive-continuum-of-metastatic-pancreatic-cancers1 2018-11-20T22:15:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-study-2 2018-11-21T02:37:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/didactic-presentation-including-real-time-video-demonstration-modifying-insulin-therapy-in-complex-and-vulnerable-patients-practical-approaches-for-switching-to-a-physiologic-basal-insulin-formulation1 2018-11-21T23:20:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session5 2019-03-26T18:58:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-challenging-morbidity-risk-and-therapeutic-continuum-of-mac-lung-disease-br-sub-what-have-we-learned-from-the-ers-treatment-guideline-real-world-experience-and-recent-trials-focused-on-high-risk/refractory-mac-lung-disease/sub 2022-09-02T01:41:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/strategies-for-incorporating-cgm-into-managed-care-medical-practice-br-sub-real-world-tactics-for-overcoming-barriers-and-improving-utilization-of-sensor-based-cgm-in-the-managed-care-practice-setting/sub 2022-04-19T05:07:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/incorporating-cgm-based-glucose-pattern-insight-reports-gpir-and-treatment-prompts-to-manage-type-2-diabetes-in-the-primary-care-setting-br-sub-refining-and-simplifying-clinical-decision-making-based-on-cgm/sub 2022-08-15T17:17:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-current-landscape-of-sensor-based-continuous-glucose-monitoring-cgm 2020-10-30T04:03:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/mainstreaming-cgm-across-the-spectrum-of-diabetes-care-what-groups-will-benefit 2021-09-27T21:14:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-case-management-of-mac-lung-disease-analyzing-evaluating-and-managing-advanced-disease-br-sub-matching-treatments-with-patient-risk-factors-and-optimizing-regimen-adherence-with-novel-inhaled-antimicrobial-formulations/sub 2022-09-02T00:04:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-cased-based-clinic-with-cgm-experts-board-focuses-on-optimizing-therapeutic-in-vulnerable-persons-with-diabetes 2024-05-14T19:23:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-physiologic-rationale-for-optimizing-ha1c-target-goal-attainment-with-basal-insulin 2018-11-21T21:43:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-expanding-foundational-role-and-practical-aspects-of-deploying-flash-based-technology-br-sub-optimizing-metabolic-health-metrics-and-clinical-outcomes-in-persons-with-diabetes/sub 2022-04-26T02:56:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-step-by-step-approach-for-launching-and-maintaining-a-cgm/agp-based-management-program-in-the-physician-associate-setting 2022-05-19T21:49:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-type-2-diabetes-focus-on-insulin-based-management-of-t2d1 2018-11-21T23:38:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/physiologic-basal-insulin-interactive-ars-case-mangemement-session-2-neil-skolnik-md-face 2018-04-18T23:24:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-data-driven-rationale-for-the-early-deployment-of-continuous-glucose-monitoring-cgm-br-sub-late-breaking-trials-and-guidance-for-initial-interventions-in-type-2-diabetes/sub1 2026-01-06T03:19:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/test 2012-05-08T19:02:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-results-of-new-mac-lung-focused-trials-evaluating-quality-of-life-improvements-ttp-and-microbial-conversion-metrics-to-optimize-antimicrobial-drug-selection 2025-03-17T18:34:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/using-cgm-data-to-optimize-diabetes-care-from-standardized-metrics-to-personalized-management 2020-06-08T23:08:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-step-by-step-approach-for-launching-and-maintaining-a-cgm/agp-based-diabetes-management-program-in-the-primary-care-setting-br-sub-what-do-i-need-to-know-to-incorporate-cgm/agp-into-my-primary-care-practice/sub 2022-07-14T21:11:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/using-cgm-based-ambulatory-glucose-profile-agp-readouts-to-improve-treatment-safety-and-efficacy-in-persons-with-t2d-br-sub-case-management-sessions-for-the-nurse-practitioner/sub 2022-06-21T20:32:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-cgm-to-improve-glycemic-control-with-aid-systems-in-type-1-diabetes-br-sub-interactive-case-study-leveraging-cgm-technology-to-optimize-glycemic-metrics/sub 2024-09-05T18:50:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-clinical-suspicion-and-co-morbid-risk-factors-to-diagnostic-confirmation-of-mac-lung-disease 2021-09-01T00:44:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-sensor-based-cgm-in-the-primary-provider-setting-br-sub-new-guidelines-provide-a-roadmap-for-better-readouts-and-better-outcomes/sub 2023-06-22T20:51:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-cgm-for-outcome-optimizing-behavioral-and-lifestyle-based-interventions 2025-03-17T19:16:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-practical-roadmap-for-using-registry-data-and-trial-based-evidence-to-guide-use-of-sensor-based-glucose-monitoring-focus-on-results-from-the-swedish-national-diabetes-register-to-optimize-multi-dose-insulin-therapy-in-persons-with-diab 2020-09-18T16:48:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/going-beyond-a1c-how-do-flash-glucose-monitoring-and-ambulatory-glucose-profile-agp-driven-care-take-diabetes-care-to-the-next-step 2022-09-15T19:33:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/why-use-continuous-glucose-monitoring-to-improve-diabetes-management-in-primary-care 2021-09-10T21:08:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-use-of-sensor-based-cgm-in-persons-with-diabetes-what-improvements-in-patient-outcomes-well-being-and-satisfaction-can-you-expect 2021-12-23T00:11:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-practical-roadmap-for-guiding-and-incorporating-sensor-based-glucose-monitoring-into-health-plans 2021-07-30T06:54:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/completing-the-journey-from-diagnosis-to-cure-in-mac-lung-disease-br-sub-translating-trial-based-results-to-real-world-side-effect-mitigating-patient-care/sub 2023-09-07T18:54:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/uptake-and-upshot 2019-03-21T23:47:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-expanding-foundational-role-of-flash-glucose-monitoring-to-cost-effectively-optimize-metabolic-health-metrics-in-persons-with-diabetes 2022-09-15T19:32:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-expert-boards-move-beyond-hba1c-br-sub-interactive-case-studies-apply-technology-based-advances-across-the-full-spectrum-of-diabetes-care/sub 2024-03-01T19:13:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-case-study-session-using-cgm-and-the-agp-report-to-improve-diabetes-management 2023-01-05T00:15:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/current-guidelines-and-recommendations-for-multimodal-management-of-non-cystic-fibrosis-bronchiectasis-br-sub-a-year-2022-2023-review/sub 2023-01-04T01:52:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management5 2019-02-12T01:26:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-step-by-step-approach-for-launching-and-maintaining-a-cgm/agp-based-management-program-in-the-family-practice-br-sub-how-do-i-work-with-available-resources-to-incorporate-cgm/agp-into-my-clinical/patient-work-flow/sub 2022-09-13T00:00:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-mandate-and-evidentiary-basis-for-flash-based-glycemic-monitoring-in-persons-with-non-insulin-managed-type-2-diabetes 2022-04-26T02:58:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/landmark-trial-based-evidence-supporting-the-efficacy-patient-outcomes-and-safety-of-pd-1-checkpoint-inhibition-in-advanced-and-metastatic-cscc 2019-03-26T18:56:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session2 2018-12-07T19:54:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/late-breaking-cost-effectiveness-rational-and-new-technological-advances-supporting-cgm-as-the-standard-of-care-for-diabetes-management-in-managed-care 2022-11-22T23:07:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer2 2018-12-07T19:51:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-technology-guideline-endorsed-screening-protocols-and-methodologies-to-optimize-detection-of-dme-and-amd-in-the-optometry-setting 2018-11-21T00:47:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/ractical-specialty-focused-strategies-for-switching-to-a-physiologic-basal-insulin-formulation 2018-11-15T06:44:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-qanda-and-discussion-sessions1 2018-11-21T02:52:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/recent-trial-pharmacoeconomic-and-real-world-data-supporting-cgm-as-a-best-pharmacy-practice-strategy-for-managing-persons-with-diabetes-br-sub-a-practical-pharmacist-based-roadmap-for-deploying-cgm-in-the-managed-care-setting/sub 2023-10-11T22:16:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-emerging-foundational-role-of-sensor-based-cgm-for-managing-diabetes-in-the-managed-care-setting 2021-10-21T00:19:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/bianco-question-1 2021-05-04T20:23:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/advancing-the-quality-and-precision-of-diabetes-care-with-sensor-based-cgm 2019-07-10T20:11:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-approaches-for-extending-progression-free-survival-pfs-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-pannet1 2018-11-21T02:35:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session1 2018-12-07T19:45:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-decision-making-for-gastrointestinal-neuroendocrine-tumors 2018-11-16T03:02:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/understanding-the-year-2020-ats/ers/escmid/idsa-guidelines-applying-evidence-based-guidelines-to-the-front-lines-of-mac-lung-management 2020-12-17T00:30:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-strategies-for-incorporating-cgm-into-managed-care-pharmacy-practice-br-sub-how-do-we-initiate-sensor-based-cgm-through-the-managed-care-pharmacy/sub 2022-03-22T18:27:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/008B1945-1485-11E5-8F860026B95664AE 2015-06-17T04:14:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/01F2E2B6-3403-11E6-BBA20026B95664AE 2016-06-23T17:28:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/01F92F30-EAB7-11E4-8F860026B95664AE 2015-04-24T23:22:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/04BB38C0-3959-11E6-BBA20026B95664AE 2016-06-23T19:43:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/05B9FFAA-7F6C-11E6-B3440026B95664AE 2016-09-20T23:58:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/06067784-2C37-11E7-9DF30026B95664AE 2017-04-28T21:24:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/06A2B2C6-3657-11E7-9DF30026B95664AE 2017-05-11T18:39:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/078FBEEE-116C-11E6-BBA20026B95664AE 2016-05-04T18:38:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/08679C79-EDE1-11E4-8F860026B95664AE 2015-04-29T00:01:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0A074A26-EDDE-11E4-8F860026B95664AE 2015-04-30T19:20:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0AC04D6D-DA4D-11E5-BBA20026B95664AE 2016-05-24T17:47:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0ADBE57E-E5A4-11E7-BD3C0026B95664AE 2018-03-26T21:38:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0BD86913-1AAB-11E5-BEAE0026B95664AE 2015-06-26T23:10:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0C05E110-7F19-11E5-BEAE0026B95664AE 2015-10-30T19:44:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0C1B22DA-8C77-11E5-BEAE0026B95664AE 2015-11-20T01:05:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0C6EDE76-F4E8-11E4-8F860026B95664AE 2015-05-07T22:38:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0CF07C20-D526-11E7-BD3C0026B95664AE 2017-11-29T21:57:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0E13425E-E4A8-11E5-BBA20026B95664AE 2016-03-18T00:49:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0E4729B6-1B70-11E5-BEAE0026B95664AE 2015-06-26T23:03:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0F013EBA-2C38-11E7-9DF30026B95664AE 2017-04-28T21:29:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0F045504-6915-11E5-BEAE0026B95664AE 2015-10-14T21:44:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0F2100EE-DA78-11E5-BBA20026B95664AE 2016-05-24T07:29:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0F2C5540-B50F-11E7-BD3C0026B95664AE 2017-10-20T00:52:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0F5CE226-DB20-11E5-BBA20026B95664AE 2016-02-25T20:35:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0F92F6D2-E4A3-11E5-BBA20026B95664AE 2016-03-18T01:00:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1016884E-B0FF-11E6-B3440026B95664AE 2016-11-23T03:02:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1019B736-6CFB-11E5-BEAE0026B95664AE 2015-10-14T18:42:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4735 2013-05-09T01:13:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/112B4F1F-E619-11E5-BBA20026B95664AE 2016-03-09T22:12:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/12C8204E-3E2B-11E6-BBA20026B95664AE 2016-06-29T22:58:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1374BDF6-DA68-11E5-BBA20026B95664AE 2016-05-24T07:49:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/140B7DF2-1B71-11E5-BEAE0026B95664AE 2015-06-26T23:02:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4040 2013-04-24T00:39:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/195B78E2-23EB-11E5-BEAE0026B95664AE 2015-07-07T21:00:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/19FEABFC-0FA1-11E5-8F860026B95664AE 2015-06-10T22:48:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1AD3EECE-3400-11E6-BBA20026B95664AE 2016-06-23T17:40:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1AE24A06-5E6E-11E6-B3440026B95664AE 2016-08-10T00:20:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1DD03FE6-1DFC-11E6-BBA20026B95664AE 2016-05-21T00:34:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1DFBDF56-2113-11E6-BBA20026B95664AE 2016-05-24T01:03:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1FDD73F0-CE28-11E7-BD3C0026B95664AE 2017-11-21T00:23:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/208F9C68-EAAA-11E4-8F860026B95664AE 2015-04-24T22:52:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/213AD9DE-5E6D-11E6-B3440026B95664AE 2016-08-10T00:15:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/22AB5316-2112-11E6-BBA20026B95664AE 2016-05-24T01:01:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/23587E0E-8980-11E6-B3440026B95664AE 2016-10-03T19:44:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/253C8D3B-EDE0-11E4-8F860026B95664AE 2015-04-30T19:02:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2662B1F2-8C76-11E5-BEAE0026B95664AE 2015-11-17T03:37:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/26BC1689-3A0F-11E6-BBA20026B95664AE 2016-06-24T17:36:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/27BAF2E0-E5A4-11E7-BD3C0026B95664AE 2017-12-20T21:44:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/28761AEE-07D7-11E5-8F860026B95664AE 2015-06-01T04:16:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2914339E-F4E7-11E4-8F860026B95664AE 2015-05-07T22:32:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/293210F6-3951-11E6-BBA20026B95664AE 2016-06-23T18:47:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2A54099E-1483-11E5-8F860026B95664AE 2015-06-17T22:33:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2BC54BD6-DB13-11E5-BBA20026B95664AE 2016-05-24T07:50:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2BD1CCFE-20D9-11E5-BEAE0026B95664AE 2015-07-02T20:54:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2BEEB2B0-8F99-11E5-BEAE0026B95664AE 2015-12-01T18:39:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2BFFE1F6-1DFD-11E6-BBA20026B95664AE 2016-05-21T00:35:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2C868156-23EA-11E5-BEAE0026B95664AE 2015-07-07T21:01:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2CE4CED6-3E2A-11E6-BBA20026B95664AE 2016-06-29T22:53:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2D2A56F6-3982-11E6-BBA20026B95664AE 2016-06-24T00:38:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2E39DC80-8731-11E6-B3440026B95664AE 2016-09-30T21:14:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2E7AEDB5-8F97-11E5-BEAE0026B95664AE 2015-12-01T18:51:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2ECDDEED-897D-11E6-B3440026B95664AE 2016-10-03T19:31:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2F4FB40E-EDDF-11E4-8F860026B95664AE 2015-04-28T23:47:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2F929A6E-EAB3-11E4-8F860026B95664AE 2015-04-24T22:55:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/30128F6E-7E59-11E5-BEAE0026B95664AE 2015-10-29T23:03:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/30AB0C1E-2C9A-11E5-BEAE0026B95664AE 2015-07-17T20:01:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/31CB2126-E631-11E5-BBA20026B95664AE 2016-03-10T01:00:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3277DB6E-DA76-11E5-BBA20026B95664AE 2016-03-22T01:22:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/32BEE6F2-B512-11E7-BD3C0026B95664AE 2017-10-27T17:43:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/32D98220-7E5A-11E5-BEAE0026B95664AE 2015-10-29T23:03:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/33600BE9-2C39-11E7-9DF30026B95664AE 2017-04-28T21:37:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/33E620D0-3952-11E6-BBA20026B95664AE 2016-06-23T18:55:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/34EDF7D5-2C98-11E5-BEAE0026B95664AE 2015-07-17T20:03:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/35AED42E-DB1E-11E5-BBA20026B95664AE 2016-03-22T01:18:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/35B8CB7E-E630-11E5-BBA20026B95664AE 2016-03-10T00:53:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/35E56086-3984-11E6-BBA20026B95664AE 2016-06-24T00:53:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/37115D98-EF4E-11E4-8F860026B95664AE 2015-04-30T19:35:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/37168E8E-AB74-11E6-B3440026B95664AE 2016-11-16T03:24:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/37F263F0-DB10-11E5-BBA20026B95664AE 2016-02-24T21:05:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/386AB5F0-3E1D-11E6-BBA20026B95664AE 2016-06-29T21:27:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/38C6DB40-B510-11E7-BD3C0026B95664AE 2017-10-20T00:59:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/39CB0ACC-7E66-11E5-BEAE0026B95664AE 2015-10-29T21:56:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3A024E10-5E6B-11E6-B3440026B95664AE 2016-08-10T00:07:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3BB5D6F0-8F95-11E5-BEAE0026B95664AE 2015-11-20T19:56:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3BD6B704-6922-11E5-BEAE0026B95664AE 2015-10-14T21:35:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3C1AC740-20DC-11E5-BEAE0026B95664AE 2015-07-06T17:42:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3C363E1E-3E37-11E6-BBA20026B95664AE 2016-06-30T00:26:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3CADBF15-07DB-11E5-8F860026B95664AE 2015-06-03T16:57:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3DE4D9CE-DB21-11E5-BBA20026B95664AE 2016-03-22T01:16:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3EE2C0AE-DA43-11E5-BBA20026B95664AE 2016-02-26T01:39:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/3F20213E-7F6A-11E6-B3440026B95664AE 2016-09-29T23:54:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/42047A56-D527-11E7-BD3C0026B95664AE 2017-11-29T22:05:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/42333D4E-3950-11E6-BBA20026B95664AE 2016-06-23T18:45:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/43B188DC-7F6D-11E6-B3440026B95664AE 2016-09-21T00:05:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/43E218FE-3C75-11E6-BBA20026B95664AE 2016-06-27T19:01:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/442B4926-9FA0-11E6-B3440026B95664AE 2016-10-31T23:32:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/44D5D0A8-1484-11E5-8F860026B95664AE 2015-06-17T04:04:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/45073C1F-1B6F-11E5-BEAE0026B95664AE 2015-06-26T23:04:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/46C198FE-DB1F-11E5-BBA20026B95664AE 2016-03-07T21:41:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/48FC2036-1B73-11E5-BEAE0026B95664AE 2015-06-26T22:59:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/499EE866-B50E-11E7-BD3C0026B95664AE 2017-10-20T00:47:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4A9AF15B-3C74-11E6-BBA20026B95664AE 2016-06-27T18:39:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4B1E2E80-7F18-11E5-BEAE0026B95664AE 2015-10-30T19:12:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4B7AE24E-3C7A-11E6-BBA20026B95664AE 2016-06-27T23:49:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4BBCCFEE-7E65-11E5-BEAE0026B95664AE 2015-10-29T21:50:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4BD57741-088D-11E5-8F860026B95664AE 2015-06-02T00:47:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4E8D246E-DA5B-11E5-BBA20026B95664AE 2016-03-22T01:24:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4ED1275B-3C7C-11E6-BBA20026B95664AE 2016-06-27T19:34:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4F22301E-20DD-11E5-BEAE0026B95664AE 2015-07-06T17:58:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4FF2AFAE-9F9F-11E6-B3440026B95664AE 2016-11-01T00:46:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5175EDAE-DA75-11E5-BBA20026B95664AE 2016-02-24T02:37:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/copy-cmr-4040 2013-04-24T00:39:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/533912D5-897F-11E6-B3440026B95664AE 2016-10-03T19:39:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/54693AE5-1DFE-11E6-BBA20026B95664AE 2016-05-21T00:36:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5482FE00-7E5C-11E5-BEAE0026B95664AE 2015-10-30T20:50:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/56B0AAF7-2114-11E6-BBA20026B95664AE 2016-05-24T01:04:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/56D012BA-CE28-11E7-BD3C0026B95664AE 2017-11-21T00:25:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5785A89E-3C7B-11E6-BBA20026B95664AE 2016-06-27T21:26:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5AA6DD60-E4A5-11E5-BBA20026B95664AE 2016-05-24T07:43:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5B1936AF-B511-11E7-BD3C0026B95664AE 2017-10-20T01:37:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5BEC499E-8980-11E6-B3440026B95664AE 2016-10-03T19:46:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5C9C87CE-3402-11E6-BBA20026B95664AE 2016-06-23T17:32:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5D0B79FA-3957-11E6-BBA20026B95664AE 2016-06-23T19:33:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5E7980A8-7F15-11E5-BEAE0026B95664AE 2015-10-30T19:04:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5EFDEF44-EA9E-11E4-8F860026B95664AE 2015-04-24T20:27:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5FB93886-CE27-11E7-BD3C0026B95664AE 2017-11-21T00:18:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/62E9D646-6920-11E5-BEAE0026B95664AE 2015-10-14T21:39:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6460C2F9-7F6B-11E6-B3440026B95664AE 2016-09-20T23:51:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/65A9B446-7E42-11E5-BEAE0026B95664AE 2015-10-30T20:30:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6603943A-7E67-11E5-BEAE0026B95664AE 2015-10-29T22:08:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/66F7DE2E-2E03-11E8-85EC0026B95664AE 2018-03-29T22:48:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/69B99E9E-210E-11E6-BBA20026B95664AE 2016-05-23T22:13:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6AF9C58B-EA98-11E4-8F860026B95664AE 2015-04-24T20:22:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6BD5959E-8C75-11E5-BEAE0026B95664AE 2015-11-17T03:48:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6CE0E456-7E41-11E5-BEAE0026B95664AE 2015-10-29T17:34:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6DFE1714-3C8E-11E6-BBA20026B95664AE 2016-06-27T21:43:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6E84D9E6-DB13-11E5-BBA20026B95664AE 2016-05-24T07:30:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6EABB1A3-3C8D-11E6-BBA20026B95664AE 2016-06-27T21:45:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/707CF07E-0F98-11E5-8F860026B95664AE 2015-06-10T21:50:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/70869C40-6923-11E5-BEAE0026B95664AE 2015-10-14T21:30:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/70A397DD-B0FE-11E6-B3440026B95664AE 2016-11-23T02:59:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/70D5BE9E-3A11-11E6-BBA20026B95664AE 2016-06-24T19:25:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/70F1D566-3951-11E6-BBA20026B95664AE 2016-06-23T18:49:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7211E596-088B-11E5-8F860026B95664AE 2015-06-01T22:37:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/72CC61D0-D526-11E7-BD3C0026B95664AE 2017-11-29T21:59:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/740367EE-FB3B-11E4-8F860026B95664AE 2015-05-15T23:50:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7454EF10-E5A4-11E7-BD3C0026B95664AE 2017-12-20T21:44:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/75863096-872F-11E6-B3440026B95664AE 2016-09-30T21:06:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/75D088CE-1177-11E6-BBA20026B95664AE 2016-05-12T22:46:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/75F85482-2C9B-11E5-BEAE0026B95664AE 2015-09-28T20:22:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/76602FE0-20DB-11E5-BEAE0026B95664AE 2015-07-02T23:05:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/76984CB1-EDDF-11E4-8F860026B95664AE 2015-04-28T23:52:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7715A445-23E8-11E5-BEAE0026B95664AE 2015-07-30T21:36:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/77A8C176-E618-11E5-BBA20026B95664AE 2016-03-09T22:02:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/77D43D5E-6CFA-11E5-BEAE0026B95664AE 2015-10-14T18:46:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/79271B8E-DE9C-11E7-BD3C0026B95664AE 2017-12-11T22:56:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7B4F3FBE-8730-11E6-B3440026B95664AE 2016-09-30T21:10:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7B79F490-DB1E-11E5-BBA20026B95664AE 2016-03-22T01:16:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7BC2845A-DB20-11E5-BBA20026B95664AE 2016-05-24T01:07:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7EFF22DE-2C38-11E7-9DF30026B95664AE 2017-04-28T21:33:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4736 2013-05-09T01:10:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7F749520-3981-11E6-BBA20026B95664AE 2016-06-24T01:12:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7FEDDCB6-3403-11E6-BBA20026B95664AE 2016-06-23T01:20:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7FEFF8DC-7E43-11E5-BEAE0026B95664AE 2015-10-29T17:48:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/805DC7F0-E4A3-11E5-BBA20026B95664AE 2016-03-18T00:57:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4420 2013-01-30T22:10:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/80E0F08E-EDE0-11E4-8F860026B95664AE 2015-04-28T23:58:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/81D8D8E0-DB10-11E5-BBA20026B95664AE 2016-02-24T21:07:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/857270D5-23E9-11E5-BEAE0026B95664AE 2015-07-07T20:57:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4422 2013-02-18T23:37:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/86245ED6-3956-11E6-BBA20026B95664AE 2016-06-23T19:27:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/86C71CF6-CE24-11E7-BD3C0026B95664AE 2017-11-21T00:10:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/885A7F40-3983-11E6-BBA20026B95664AE 2016-06-24T00:51:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/89234A90-CE26-11E7-BD3C0026B95664AE 2017-11-21T00:12:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/898B6F4C-897E-11E6-B3440026B95664AE 2016-10-03T19:34:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8A0732E6-DB12-11E5-BBA20026B95664AE 2016-03-22T01:21:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8A7DFE8E-7F12-11E5-BEAE0026B95664AE 2015-10-30T18:36:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8B1D02E0-D525-11E7-BD3C0026B95664AE 2017-11-29T21:53:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8B869748-E746-11E7-BD3C0026B95664AE 2017-12-22T23:35:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8C42F33F-7E66-11E5-BEAE0026B95664AE 2015-10-30T17:49:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8CA7C1BB-AB70-11E6-B3440026B95664AE 2016-11-16T02:51:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8CF3ACB6-3952-11E6-BBA20026B95664AE 2016-06-23T18:57:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8DA9687B-F4E7-11E4-8F860026B95664AE 2015-05-12T00:11:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8EDE4A7E-DB1F-11E5-BBA20026B95664AE 2016-02-24T22:55:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8EE03200-2DDD-11E8-85EC0026B95664AE 2018-03-29T20:15:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8F2D9470-8F9B-11E5-BEAE0026B95664AE 2015-12-02T02:31:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/923CF2A6-3955-11E6-BBA20026B95664AE 2016-06-23T21:06:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9306AC96-DB21-11E5-BBA20026B95664AE 2016-03-22T01:15:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9357694E-1B6E-11E5-BEAE0026B95664AE 2015-06-26T23:08:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/941CEE1E-8731-11E6-B3440026B95664AE 2016-09-30T21:17:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9586188E-E5A4-11E7-BD3C0026B95664AE 2017-12-22T23:37:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/96497773-2C37-11E7-9DF30026B95664AE 2017-04-28T21:26:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/97151CDE-1484-11E5-8F860026B95664AE 2015-06-17T04:07:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9965DB00-A8BE-11E5-BEAE0026B95664AE 2015-12-22T21:41:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9B348D2E-7E64-11E5-BEAE0026B95664AE 2015-10-29T21:46:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9B8DA1FE-D52B-11E7-BD3C0026B95664AE 2017-11-29T22:36:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9B9A04F0-8C76-11E5-BEAE0026B95664AE 2015-11-17T03:39:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9BE607A6-E703-11E5-BBA20026B95664AE 2016-03-18T00:26:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9D09E2E0-0F96-11E5-8F860026B95664AE 2015-06-10T21:40:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9D6278E2-9FA7-11E6-B3440026B95664AE 2016-11-01T00:38:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9D64C576-AB71-11E6-B3440026B95664AE 2016-11-16T02:20:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9FB25386-CE27-11E7-BD3C0026B95664AE 2017-11-21T00:21:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A003B3F8-3C7B-11E6-BBA20026B95664AE 2016-06-27T19:28:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A18B7326-6CFB-11E5-BEAE0026B95664AE 2015-10-14T18:59:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A1B61086-7E5D-11E5-BEAE0026B95664AE 2015-10-29T23:02:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A267E4F6-3955-11E6-BBA20026B95664AE 2016-06-25T00:56:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A3A386EE-EA94-11E4-8F860026B95664AE 2015-04-24T19:26:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A5C841C0-5F17-11E6-B3440026B95664AE 2016-08-22T23:25:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A6623A6E-6CF9-11E5-BEAE0026B95664AE 2015-10-14T18:48:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A67FDAE1-1158-11E6-BBA20026B95664AE 2016-05-04T18:39:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A80F41C8-FB38-11E4-8F860026B95664AE 2015-05-15T23:30:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-accuracy-of-sensor-based-cgm-br-sub-implications-for-interpretation-of-ambulatory-glucose-profiles-agps-and-time-in-range-across-the-full-spectrum-of-persons-with-diabetes/sub 2022-05-27T21:51:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/chair-s-vision-statement-and-data-to-clinic-translational-summary 2018-12-27T21:01:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-based-real-world-applications-of-sensor-based-cgm-to-the-front-lines-of-diabetes-care 2019-07-10T20:11:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-aspects-of-switching-to-a-physiologic-basal-insulin-formulation-vivian-fonseca-md-frcp-program-chair 2018-04-18T23:17:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc1 2018-11-27T21:04:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/patient-management-sessions-putting-cgm-into-practice-in-the-real-world-br-sub-using-individualized-agp/gpir-reports-and-glycemic-metrics-to-move-beyond-hba1c-to-optimize-health-outcomes-in-diabetes/sub 2023-06-21T22:44:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-sensor-based-cgm-as-a-best-practice-strategy-for-managing-persons-with-diabetes-in-the-managed-care-setting 2022-04-19T05:06:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session-faculty-panel1 2019-02-08T00:04:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/sensor-based-cgm-in-the-managed-care-setting-the-managed-care-pharmacist-s-cost-based-perspective 2021-10-21T00:20:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-qanda-session1 2019-06-25T22:27:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-landmark-trials-to-evidence-based-therapy-for-resistant-refractory-high-risk-and/or-challenging-patients-with-mac-lung-infection 2021-09-01T00:42:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-decision-making-for-gastrointestinal-neuroendocrine-tumors-nets-translating-disease-type-progression-profiles-biomarkers-and-the-safety-efficacy-equation-for-available-therapies-into-optimal-clinical-management 2018-11-15T08:20:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/what-do-we-know-what-do-we-still-need-to-know 2018-11-15T09:29:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/year-2018-acc-guideline-update-the-ecdp-report-on-non-statin-therapies-for-ashd-reduction-in-diabetic-patients-addressing-statin-intolerance-poor-target-ldl-goal-attainment-and-resistance-syndromes-in-diabetes-specialty-practice 2018-11-15T05:49:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-evidence-and-guideline-directed-advances-in-antimicrobial-treatment-for-mac-lung-disease 2023-06-21T22:42:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-directed-management-to-improve-outcomes-in-persons-with-t2d-br-sub-using-cgm-to-optimize-therapy-at-the-front-lines-of-diabetes-care/sub 2022-06-21T20:35:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management2 2018-12-07T19:53:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/gep-net-current-evidence-and-treatment-landscape 2018-11-21T21:02:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-current-updated-ats/idsa/ers-guidelines-for-ntm-ld-to-the-front-lines-of-specialty-practice 2021-12-14T04:51:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evidence-for-prompt-intensive-intervention-in-risk-appropriate-patients-with-mac-lung-disease 2021-09-01T00:43:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/foundational-and-evolving-approaches-to-multimodal-management-of-non-cystic-fibrosis-bronchiectasis-ncfbe-br-sub-the-role-of-inflammation-vs-infection-in-disease-exacerbation/sub 2022-05-09T19:42:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/moving-beyond-a1c-establishing-a-new-personalized-precision-based-standard-for-glycemic-management-of-persons-with-type-2-diabetes 2023-05-18T21:08:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/patient-management-case-studies-putting-cgm-into-practice-in-the-real-world-br-sub-using-individualized-agp/gpir-reports-and-glycemic-metrics-to-move-beyond-hba1c-to-optimize-health-outcomes-in-diabetes/sub 2023-06-22T20:50:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/vr 2021-04-11T19:31:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-new-trial-based-evidence-guidelines-and-individualized-approaches-to-real-world-management-for-mac-lung-disease 2024-09-05T22:16:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-diabetes-and-primary-care-specialist-s-perspective-on-prevention-of-inevitable-blindness-in-the-patient-with-diabetes-focus-on-the-importance-of-prompt-referral 2021-01-22T20:09:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/maximizing-patient-engagement-and-satisfaction-with-sensor-based-glucose-monitoring-new-real-world-data-confirming-patient-centric-preferences-for-cgm-based-care 2023-02-17T22:05:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diabetes-management-case-study-2 2018-11-21T23:18:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-landscape-of-sensor-based-technology-for-optimizing-clinical-outcomes-across-the-comprehensive-spectrum-of-type-2-and-type-1-diabetes-care 2020-06-08T23:07:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-aspects-of-establishing-and-deploying-cgm-at-the-front-lines-of-care-for-t2d-br-sub-barriers-solutions-and-patient-identification/sub 2022-05-27T21:52:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-critical-role-of-longitudinal-microbiologic-monitoring-in-mac-lung-disease-br-sub-the-potential-pitfalls-of-a-watch-and-wait-approach-in-high-risk-patients/sub 2023-09-07T17:09:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/beyond-a1c-using-cgm-to-provide-precision-diabetes-management 2023-01-05T00:14:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-sensor-based-glucose-monitoring-technology 2020-06-08T23:08:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session4 2019-02-12T01:29:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-application-of-established-and-emerging-therapies-and-technologies-for-patients-with-gep-nets 2018-11-15T09:26:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-sensor-based-cgm-in-the-primary-provider-setting 2023-05-19T22:05:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-emerging-foundational-role-of-sensor-based-cgm-for-managing-diabetes-br-sub-new-trends-in-reimbursement-for-continuous-glucose-monitoring-in-insulin-dependent-patients/sub 2023-10-11T22:15:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-to-screen-and-intervene-in-the-optometry-setting-to-prevent-blindness-under-utilization-of-screening-dilated-eye-exams-and-technologies-across-the-continuum-of-macular-degenerative-conditions1 2018-11-21T02:56:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/using-cgm-based-glycemic-management-and-agp-readouts-to-improve-diabetes-management-and-outcomes-for-persons-with-t2d-cared-for-in-the-physician-associate-setting-br-sub-interactive-case-management-sessions/sub 2022-05-22T18:04:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management4 2019-02-08T00:03:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/early-application-of-cgm-to-proactively-manage-type-2-diabetes-in-the-real-world-interactive-case-based-clinic 2024-06-22T17:42:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-introductory-fundamentals-of-sensor-based-cgm-a-primary-care-specialist-s-perspective 2022-07-22T18:27:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-data-to-patient-practical-implementation-of-flash-glucose-monitoring-br-sub-how-to-monitor-interpret-and-improve-time-in-range-tir-gmi-and-agp-in-persons-with-type-2-diabetes/sub 2022-09-15T19:33:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/diabetes-management-case-study-1 2018-11-21T23:08:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-based-roadmaps-for-reducing-hospitalizations-and-cv-mortality-in-t2d-br-sub-interactive-case-study-improving-clinical-outcomes-in-vulnerable-persons/sub 2024-09-05T18:51:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-clinical-implications-of-using-hybrid-capturing-ngs-in-lung-cancer-the-journey-from-genomic-alterations-to-optimizing-targeted-therapy-at-the-front-line-of-oncology-practice-professor-nir-peled-md-phd-program-chair 2018-11-21T02:30:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-cgm/agp-based-management-of-persons-with-t2d-in-the-physician-associate-setting-br-sub-what-do-the-studies-and-guidelines-teach-us/sub 2022-05-20T16:53:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/0417DACE-2E00-11E8-85EC0026B95664AE 2018-03-22T22:38:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session-7839 2018-11-17T01:47:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-emerging-date-to-real-world-care-for-adult-patients-with-t1d 2018-11-21T23:09:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/086282A6-4C92-11E8-A96B0026B95664AE 2018-04-30T20:18:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/challenges-and-questions-1-interactive-dialogue-session-with-faculty-facilitated-analysis-and-discussion-focused-on-ngs-technologies-for-genomics-driven-cancer-medicine 2018-11-21T02:05:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/09DDFDDE-DE9B-11E7-BD3C0026B95664AE 2017-12-11T22:46:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-call-to-action-preventing-inevitable-blindness-in-the-diabetic-patient-br-sub-forming-critical-clinical-partnerships-and-protocols-with-our-optometry-and-retina-specialist-colleagues/sub 2021-06-17T23:24:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/critical-advances-in-mitigating-progression-of-inevitable-diabetic-eye-disease-br-sub-integrating-new-therapeutic-advances-in-diabetic-eye-disease-to-the-front-lines-of-specialty-and-primary-care/sub 2021-06-17T23:21:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-current-and-future-roadmap-to-optimizing-glycemic-control-in-t2d-with-physiologic-long-acting-basal-insulin-the-evidence-guideline-and-mechanistic-rationale-for-long-acting-physiologic-basal-insulin 2018-11-02T00:11:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/10D2A4D0-3660-11E7-9DF30026B95664AE 2017-05-15T17:16:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-real-world-data-to-the-practical-aspects-of-front-line-care 2021-06-22T21:52:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/115E900C-4E45-11E8-A96B0026B95664AE 2018-05-03T00:12:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/technological-behavioral-and-practical-aspects-of-using-real-time-glucose-alarms 2021-03-31T18:34:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-study-and-t2d-clinical-decision-tree-simulation-ars-based-interactive-session-focused-on-patient-with-t2d 2018-11-08T19:47:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-case-management-session-and-t2d-clinical-decision-tree-simulation-3-complementary-antiglycemic-combinations 2018-11-21T21:37:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/advancing-the-treatment-frontside-for-metastatic-pancreatic-adenocarcinoma-pdac-and-pnet 2018-11-21T04:29:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/didactic-presentation-including-real-time-video-demonstration-modifying-insulin-therapy-in-complex-and-vulnerable-patients-practical-approaches-for-switching-to-a-physiologic-basal-insulin-formulation 2018-11-02T00:04:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-long-acting-insulins-are-not-created-equal-how-are-they-similar-how-are-they-critically-different-pablo-f-mora-md-face 2018-11-01T21:52:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/preventing-inevitable-blindness-in-the-diabetic-patient-optimizing-management-and-treatment-strategies-for-diabetic-macular-edema 2021-01-28T00:54:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/1834960E-0542-11E8-BD3C0026B95664AE 2018-01-30T03:25:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-importance-of-cgm/agp-based-management-of-persons-with-t2d-in-the-primary-care-setting 2022-04-02T00:59:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-approaches-for-extending-progression-free-survival-pfs-and-symptom-management-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-pannet 2018-11-15T02:43:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-evidence-supporting-superior-glycemic-control-with-flash-glucose-monitoring-across-the-spectrum-of-diabetes-care 2021-05-27T21:24:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/welcome-and-introduction-the-unmet-therapeutic-needs-for-moderate-to-severe-atopic-dermatitis-ad-what-works-what-doesn-t-what-do-we-still-need-to-know-to-improve-patient-outcomes-in-patients-with-persistent-and/or-resistant-ad 2018-11-09T22:19:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-sensor-based-glucose-monitoring-cgm-to-reduce-cost-intensive-adverse-drug-events-associated-with-diabetes-treatment-eric-cannon-pharmd 2021-04-16T00:32:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-optometrist-s-role-in-diagnosing-and-managing-patients-with-diabetic-retinopathy-focus-on-the-importance-of-prompt-referral-014543 2021-01-22T20:16:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-the-safety-efficacy-equation-for-comprehensive-glycemic-regulation-in-complex-patients-with-t2d-the-physiologic-rationale-for-complementary-pharmacologic-approaches-based-on-insulin-plus-incretin-system-targeting-agents 2018-11-21T23:19:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/therapeutic-advances-patient-adherence-and-novel-formulations-for-the-treatment-of-mycobacterium-avium-complex-mac-lung-disease-webinar 2019-10-04T20:19:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathophysiology-risk-factors-profiles-and-clinical-manifestations-of-age-related-macular-generation-amd-and-diabetic-edema-dme2 2018-11-21T03:46:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer 2018-12-07T19:48:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-practical-roadmap-for-insulin-based-management-switching-selection-and-sustainability-of-long-acting-insulin-formulations 2018-11-01T21:54:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-and-complex-landscape-of-detecting-assessing-and-managing-iron-deficiency-anemia-in-the-oncology-and-hematology-specialty-setting 2018-11-21T03:56:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc5 2019-02-12T01:28:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-clinical-outcome-and-success-roadmap-for-mac-ld 2021-12-28T01:40:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/program-co-chairs-and-faculty-provide-up-to-the-minute-analysis-and-discussion-of-top-10-faqs-submitted-by-diabetes-endocrine-and-metabolism-specialist 2018-11-21T23:10:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-pharmacy-vs-medical-benefits-perspective-for-adopting-sensor-based-glucose-monitoring-in-the-managed-care-setting-kenneth-schaecher-md 2021-04-16T01:15:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/2989B670-4C91-11E8-A96B0026B95664AE 2018-04-30T20:12:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/esmo-asia-2016-an-oncologist-s-bid-to-personalise-patient-care-with-genomic-profiling-dr-wong-seng-weng-medical-director-and-consultant-medical-oncologist 2018-11-21T03:40:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-treatment-landscape-in-evolution-new-strategies-guidelines-and-therapeutic-advances-for-metastatic-pancreatic-adenocarcinoma-what-do-we-know-what-do-we-still-need-to-know-what-are-the-unmet-needs-in-advanced-disease 2018-11-12T19:54:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-melanoma 2019-08-29T18:09:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-glycemic-control-while-mitigating-hypoglycemic-risk-in-challenging-patients-with-t2d 2018-11-01T23:13:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-approaches-for-extending-progression-free-survival-pfs-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-pannet 2018-11-16T20:31:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/315D4046-0544-11E8-BD3C0026B95664AE 2018-01-30T03:35:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/31987B9E-365B-11E7-9DF30026B95664AE 2017-05-11T19:54:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/31F1E857-4E44-11E8-A96B0026B95664AE 2018-05-03T00:07:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-epidemiology-disease-burden-and-demographics-of-diabetes-associated-and-age-related-macular-degenerative-disease2 2018-11-21T03:44:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-to-screen-and-intervene-in-the-optometry-setting-to-prevent-blindness-under-utilization-of-screening-dilated-eye-exams-and-technologies-across-the-continuum-of-macular-degenerative-conditions2 2018-11-21T03:25:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/35ED23FE-4C92-11E8-A96B0026B95664AE 2018-04-30T20:20:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-management-of-ida-the-oncology-and-hematology-specialist-s-perspective-interactive-case-management-simulations-using-audience-response-system-ars 2018-11-21T19:34:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/post-program-interactive-dialogue-discussion-and-qanda-session 2018-11-17T02:00:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-type-2-diabetes-focus-on-insulin-based-management-of-t2d 2018-11-02T00:12:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/37C94F56-4E45-11E8-A96B0026B95664AE 2018-05-03T00:14:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-mediated-improvements-in-ha1c-and-regimen-adherence-in-the-setting-of-glp-1-agonists1 2025-05-14T20:12:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-early-screening-detection-and-referral-of-patients-with-nonproliferative-diabetic-retinopathy-npdr-the-evidence-for-time-sensitive-anti-vegf-therapy-for-preventing-inevitable-blindness-in-persons-with-diabetes 2022-06-03T01:03:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evidence-based-journey-from-targets-to-therapy-comprehensive-genomic-profling-to-optimize-precision-focused-cancer-management 2018-11-20T22:41:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/what-the-cardiologist-needs-to-know-about-oral-versus-iv-iron-repletion 2018-11-14T22:09:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session-qanda 2018-11-09T22:35:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/which-patients-with-advanced-cscc-will-likely-benefit-most-from-pd1-checkpoint-inhibition 2018-12-01T04:43:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/improvements-in-health-system-outcomes-and-bottom-line-budget-and-pharmacoeconomic-impacts-associated-with-the-use-of-sensor-based-cgm-across-the-diabetes-spectrum 2021-06-22T21:48:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-case-management-session-and-t2d-clinical-decision-tree-simulation-1-complementary-antiglycemic-combinations 2018-11-21T21:34:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/449EE4BA-0DD1-11E8-85EC0026B95664AE 2018-02-10T00:42:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/unmet-therapeutic-needs-in-adult-patients-with-type-1-diabetes 2018-11-21T23:01:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-mediated-improvements-in-hba1c-and-noninsulin-regimen-adherence 2025-09-08T19:59:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/452A0BA6-DE9B-11E7-BD3C0026B95664AE 2017-12-11T22:48:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundation-role-of-iv-iron-repletion-for-the-patient-with-hematologic-disorders-and-oncologic-malignancies-associated-with-ida-what-have-the-clinical-trials-taught-us-where-does-the-evidence-lead-us 2018-11-21T19:33:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/addressing-the-complex-metabolic-safety-efficacy-and-compliance-and-ha1c-target-needs-of-challenging-t2d-patients-managed-in-the-specialty-setting 2018-11-08T20:08:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interpretation-of-sensor-based-glucose-metrics-time-in-range-tir-and-ambulatory-glucose-profiles-agp-moduleandnbsp-2-personalize 2020-12-03T18:36:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-colorectal-cancer 2019-03-27T00:06:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/qanda-session-and-special-hot-topics-session-hot-topics-in-diabetes-the-co-chairs-and-faculty-provide-up-to-the-minute-analysis-and-discussion-of-top-10-faqs-submitted-by-diabetes-endocrinology-internal-medicine-and-primary-care-physicia 2018-11-21T20:15:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-for-improving-residual-cardiovascular-disease-risk-reduction-in-patients-with-adversely-elevated-ldl-c 2018-11-14T22:35:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/question-and-answer-session 2018-11-01T22:03:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-technology-screening-protocols-and-methodologies-to-optimize-detection-of-dme-and-amd-in-the-optometry-setting 2018-11-21T03:52:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-the-safety-efficacy-equation-in-complex-t2d-patients-with-fixed-ratio-basal-insulin-plus-a-short-acting-glp-1-ra-combination-regimen-juan-p-frias-md-face-program-co-chair 2018-11-08T19:37:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/basal-insulin-interactive-ars-case-management-session-2-optimizing-glycemic-control-in-the-older-or-elderly-patient-with-t2d-at-risk-for-hypoglycemia 2018-11-02T00:02:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-cgm-to-optimize-blood-glucose-tir-quality-of-life-and-health-metrics-across-the-spectrum-of-diabetes-care-in-the-managed-care-setting 2021-08-06T19:57:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-management-and-treatment-strategies-in-diabetic-eye-disease 2018-11-21T03:59:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-ngs-and-actionable-genomic-alterations-to-patients-with-tumor-of-unknown-etiology-professor-pang 2018-11-21T20:38:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-basal-insulins-are-not-created-equal 2018-11-21T19:47:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/what-do-recent-landmark-cardiovascular-outcome-trials-evaluating-pcsk9-inhibition-in-high-risk-patient-populations-teach-us 2018-11-14T22:45:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5081725E-DE9A-11E7-BD3C0026B95664AE 2017-12-11T22:41:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5136BE66-0543-11E8-BD3C0026B95664AE 2018-01-30T03:26:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/51AFE166-4C91-11E8-A96B0026B95664AE 2018-04-30T20:14:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/52E2E456-3659-11E7-9DF30026B95664AE 2017-05-11T18:58:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-physiologic-rational-for-optimizing-ha1c-target-goal-attainment-with-basal-insulin-mechanisms-patient-selection-and-sequencing-strategies 2018-11-01T23:54:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-snp-based-diagnostic-tests-for-detecting-the-full-range-of-fetal-abnormalities 2018-11-17T01:35:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/546BE105-DE9C-11E7-BD3C0026B95664AE 2017-12-11T22:55:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/comprehensive-genomic-profiling-of-gynaecological-cancers-to-optimize-therapy-a-science-to-practice-update-dr-david-sp-tan 2018-11-21T03:32:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-treatment-landscape-in-evolution-new-strategies-guidelines-and-therapeutic-advances-for-metastatic-pancreatic-adenocarcinoma 2018-11-16T22:32:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/welcome-and-introduction-the-efficacy-and-safety-rationale-for-complementary-multi-mechanistic-approaches-in-t2d-vivian-a-fonseca-md-program-co-chair 2018-11-08T20:09:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/5C6FD81C-4C92-11E8-A96B0026B95664AE 2018-04-30T20:21:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/advancing-the-treatment-frontiers-for-metastatic-pancreatic-adenocarcinoma-focus-on-molecular-markers-new-precision-based-technologies 2018-11-12T23:39:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-physiologic-basis-for-optimizing-ha1c-target-goal-attainment-in-t2d 2018-11-01T21:47:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session3 2018-11-21T19:31:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-decision-making-for-metastatic-pancreatic-adenocarcinoma2 2018-11-21T04:27:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cgm-for-transforming-clinical-outcomes-in-non-intensive-t2d-therapy 2026-03-09T20:53:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/64D2A846-4E44-11E8-A96B0026B95664AE 2018-05-03T00:08:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-cgm-for-personalized-a1c-optimization 2025-09-08T22:53:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/getting-real-world-and-hands-on-in-patients-with-elevated-ldl-c-and-high-risk-features-for-atherosclerotic-cardiovascular-disease-interactive-case-management-sessions 2018-09-26T22:42:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/65EA81F4-365F-11E7-9DF30026B95664AE 2017-05-11T19:39:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-breast-cancer 2019-05-31T22:15:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6806A108-2E01-11E8-85EC0026B95664AE 2018-03-29T20:28:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-profound-positive-impact-of-cgm-on-glycemic-control-and-patient-engagement1 2025-05-14T20:12:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session-your-questions-perspectives-and-discussion-points 2018-11-21T04:04:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/ars-based-interactive-session-focused-on-a-complex-patient-with-t2d-who-has-a-high-risk-for-hypoglycemia-is-overweight-and-despite-basal-insulin-therapy-has-significantly-elevated-post-prandial-glucose-levels 2018-11-21T23:22:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/an-ars-based-interactive-session-focused-on-the-patient-with-t2d-who-requires-pan-glycemic-fpg-and-ppg-control-is-averse-to-multiple-daily-injections-and-needs-to-lose-weight-and-improve-overall-ha1c-levels 2018-11-21T23:23:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/welcome-and-introduction-program-chair-the-physiologic-basis-and-practical-rationale-for-fixed-ratio-insulin-glp-1-ra-combinations 2018-11-21T20:12:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/6B7D74FE-0540-11E8-BD3C0026B95664AE 2018-01-30T03:13:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/current-and-evolving-national-guidelines-for-deploying-nipt-in-average-and-high-risk-populations-ruma-md-mph 2018-11-17T01:39:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-range-specificity-and-sensitivity-of-genomic-focused-technologies-available-for-identifying-molecular-drivers-for-targeted-cancer-therapy 2018-11-21T01:20:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-targets-into-therapy-the-pathoimmunobiology-of-atopic-dermatitis-focus-on-novel-treatments-and-the-role-of-immune-mediated-inflammation-in-ad-emma-guttman-md-phd 2018-11-09T22:22:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-optometrist-s-foundational-role-in-screening-diagnosis-and-referral-persons-with-diabetic-eye-disease-br-sub-forging-a-critical-partnership-with-the-diabetes-primary-care-and-retina-specialist-to-optimize-outcomes/sub 2021-06-17T23:23:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7067159E-0DD1-11E8-85EC0026B95664AE 2018-03-22T18:51:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management1 2018-12-07T19:50:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-current-state-of-preventing-dka-burden-shortcomings-and-new-opportunities 2026-03-09T20:49:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-colorectal-cancer1 2019-12-10T07:42:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-needs-and-strategies-for-the-hematology-consultant-late-breaking-trials-and-guidelines-for-iv-iron-repletion-in-the-setting-of-heart-failure 2018-11-21T01:29:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-for-individualized-care-in-persons-with-ntm-lung-disease-and-limited-options 2025-09-26T20:19:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-ngs-and-actionable-genomic-alterations-to-patients-with-lung-cancer-professor-yang 2018-11-21T20:29:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-ngs-and-actionable-genomic-alterations-to-patients-with-lung-cancer-professor-peled 2018-11-21T19:56:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management6 2019-02-12T01:29:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/addressing-the-challenges-safety-needs-and-target-goal-considerations-of-complex-and-high-risk-patients-with-diabetes 2018-11-01T21:50:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-for-applying-sensor-based-cgm-at-the-front-lines-of-diabetes-care-focus-on-optimizing-outcomes-in-persons-requiring-insulin-and-combination-insulin-based-treatments-the-role-of-agps-for-refining-therapeutic-interventions 2021-03-19T18:57:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-physiologic-foundational-and-multi-mechanistic-approach-for-employing-insulin-based-regimens-in-primary-care-and-specialty-practice 2018-11-21T21:35:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7B95E5B8-0DD0-11E8-85EC0026B95664AE 2018-02-10T00:37:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-clinical-action-plans-screen-and-intervene-case-management-session 2018-11-21T04:02:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-guideline-sanctioned-interventions-for-pancreatic-cancer-applying-the-best-practice-roadmap-of-recent-nccn-guidelines-to-optimize-survival-extension-in-metastatic-pancreatic-adenocarcinoma 2018-11-12T19:57:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-to-optimize-comprehensive-glycemic-and-metabolic-management-in-adult-patients-with-t1dm 2018-11-21T23:07:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-study-41 2018-11-21T04:07:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/identifying-patients-who-are-ideal-candidates-for-nanoliposomal-topoisomerase-inhibitors-in-metastatic-pancreatic-adenocarcinoma 2018-11-17T01:56:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-physiologic-and-evidence-basis-for-deploying-long-acting-insulin-formulatings-in-diabetes-specialty-care 2018-11-01T22:01:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/7FF9B8A0-0543-11E8-BD3C0026B95664AE 2018-01-30T22:59:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-session-7503 2018-11-14T22:14:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-intersection-of-trial-data-and-real-world-evidence-for-the-application-of-sensor-based-glucose-monitoring-technology-for-the-diabetes-and-primary-care-specialist 2021-07-23T21:36:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-guidelines-meta-analysis-and-real-world-trials-to-guide-practical-aspects-of-diabetes-care-in-the-managed-care/hmo-setting 2021-04-09T20:16:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-decision-making-for-metastatic-pancreatic-adenocarcinoma 2018-11-16T20:27:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8571BBDE-DE9B-11E7-BD3C0026B95664AE 2017-12-11T22:49:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/question-and-answer-session1 2018-11-16T20:35:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-cgm-technologies-into-real-world-case-based-management-across-the-full-spectrum-of-diabetes-cares-br-sub-interactive-case-study-session/sub 2025-05-14T20:14:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/8B57A64E-4E44-11E8-A96B0026B95664AE 2018-05-03T00:09:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/treatment-of-advanced-nsclc-based-on-genomic-analysis-of-the-tumor-james-chih-hsin-yang-m-d-ph-d-professor-and-director-graduate-institute-of-oncology-ntu 2018-11-21T02:25:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-ngs-and-actionable-genomic-alterations-to-patients-with-breast-cancer-professor-dent 2018-11-21T20:21:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-study-and-t2d-clinical-decision-tree-simulation-1-ars-based-interactive-session-focused-on-patient-with-t2d-who-is-on-metformin-and-sglt-2-inhibitor 2018-11-08T20:09:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interpretation-of-sensor-based-glucose-metrics-time-in-range-tir-and-ambulatory-glucose-profiles-agp-moduleandnbsp-1-analyze 2020-12-03T18:35:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-intersection-of-flash-glucose-monitoring-technology-and-real-world-care-in-persons-with-diabetes 2021-05-27T21:23:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/risk-directed-therapy-for-ad-aligning-the-ad-toolkit-with-patient-specific-disease-severity 2018-11-14T00:05:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/guidelines-and-the-role-of-non-statin-therapies-for-ascvd-reduction-in-high-risk-patients-addressing-statin-intolerance-and-poor-target-ldl-c-goal-attainment 2018-09-26T22:35:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/consultative-challenges-in-the-diagnosis-and-management-of-iron-deficiency-anemia-ida-across-the-ida-morbidity-continuum 2018-11-21T01:29:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-critical-role-of-postprandial-hyperglycemia-ppg-in-difficult-to-manage-diabetic-patients-strategies-for-measuring-ppg-and-assessing-the-contribution-of-ppg-to-overall-glycemic-dysregulation-in-the-challenging-diabetic-patient 2018-11-21T23:20:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-case-studies-and-ars-mediated-case-management-discussions-applying-science-guidelines-and-landmark-trial-based-evidence 2018-11-13T00:00:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/advancing-the-treatment-frontiers-for-metastatic-pancreatic-adenocarcinoma-and-pannet-fadi-braiteh-md 2018-11-16T19:38:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/90F8F0E0-4C92-11E8-A96B0026B95664AE 2018-04-30T20:22:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/91D177C1-365A-11E7-9DF30026B95664AE 2017-05-11T19:04:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-relationship-between-iron-deficiency/iron-deficiency-anemia-and-functional-outcomes-in-patients-with-heart-failure-and-related-co-morbid-conditions 2018-11-14T22:01:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/treatment-decisions-for-ntm-pd-an-international-guideline-based-approach-to-optimizing-outcomes-in-mac-lung-disease 2021-02-05T01:19:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/practical-considerations-of-snp-based-aneuploidy-testing-errol-r-norwitz-md-phd-mba 2018-11-17T01:37:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9870F957-DE9A-11E7-BD3C0026B95664AE 2017-12-11T22:43:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-strategies-for-proliferative-diabetic-retinopathy-the-role-of-screening-anti-vegf-therapy-and-optometrist-generated-referral-to-a-retinal-specialist-to-maximize-blindness-prevention-in-persons-with-diabetes 2021-03-02T20:12:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/case-based-analysis-and-interpretation-of-ngs-diagnostic-reports-and-immuno-oncology 2019-06-28T01:49:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-iv-iron-repletion-for-patients-with-heart-failure 2018-11-14T22:07:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-guideline-sanctioned-interventions-for-pancreatic-cancer-applying-the-best-practice-roadmap-of-recent-nccn-guidelines-to-optimize-survival-extension-in-metastatic-pancreatic-adenocarcinoma1 2018-11-17T01:55:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-landscape-of-sodium-glucose-co-transporter-sglt2-and-sglt1-inhibitors 2018-11-21T23:08:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/9E058706-3652-11E7-9DF30026B95664AE 2017-05-11T18:16:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-case-based-master-session-on-treatment-of-mac-lung-disease-the-intersection-of-new-ats/idsa-guidelines-and-clinical-decision-making-at-the-front-lines-of-specialty-care 2021-03-18T23:00:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-therapies-for-optimizing-outcomes-in-diabetic-retinopathy-br-sub-the-foundational-role-of-the-retina-specialist-as-part-of-the-clinical-care-team-for-preventing-dr-related-blindness-in-persons-with-diabetes/sub 2021-06-17T23:23:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-blindness-prevention-treatment-strategies-for-diabetic-retinopathy-dr-a-case-based-focus-on-screening-and-prompt-referral-to-a-retina-specialist 2021-02-25T00:44:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A2BFC4EE-2DFE-11E8-85EC0026B95664AE 2018-03-22T22:34:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-prostate-cancer 2019-07-27T01:06:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/basal-insulin-interactive-ars-case-management-session-3 2018-11-02T00:05:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-lung-cancer 2019-03-01T06:27:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-evidence-to-optimal-management-of-gep-nets1 2018-11-21T04:05:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-landmark-trial-based-evidence-to-the-front-lines-of-care-for-pancreatic-cancer-the-evolving-trial-based-and-guideline-supported-role-for-nanoliposomal-topoisomerase-inhibitors-in-metastatic-pancreatic-adenocarcinoma 2018-11-12T21:27:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-case-management-session-and-t2d-clinical-decision-tree-simulation-2-complementary-antiglycemic-combinations 2018-11-21T21:36:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/qanda-session-and-special-hot-topics-session 2018-11-21T23:24:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-physiologic-and-mechanistic-basis-for-long-acting-basal-insulin-in-t2d-the-evidence-for-basal-insulin-as-initial-foundational-therapy-for-challenging-patients-requiring-comprehensive-fpg-and-ppg-glycemic-control 2018-11-21T23:21:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/antimicrobial-decision-making-in-mac-lung-disease-optimizing-treatment-outcomes-and-microbial-conversion 2025-09-26T20:20:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A854E897-CE28-11E7-BD3C0026B95664AE 2017-11-21T00:27:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A8810B2C-897F-11E6-B3440026B95664AE 2016-10-03T19:41:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A8A4A058-0DD0-11E8-85EC0026B95664AE 2018-02-10T00:39:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-practical-and-mechanistic-role-of-short-acting-glp-1-receptor-agonists-for-managing-ppg-in-complex-patients-already-on-basal-insulin-how-do-short-acting-glp-1-ras-optimize-the-safety-benefit-equation-in-patients-requiring-pan-glycemi 2018-11-21T23:22:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A9160856-2C99-11E5-BEAE0026B95664AE 2015-07-17T20:02:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/A9C36DAE-1DFC-11E6-BBA20026B95664AE 2016-05-21T00:34:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AB0BEB96-23EB-11E5-BEAE0026B95664AE 2015-07-07T20:58:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AC54F30E-7F6D-11E6-B3440026B95664AE 2016-09-21T00:42:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/ACAA5FAE-0541-11E8-BD3C0026B95664AE 2018-01-30T03:16:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AD07AB27-B50E-11E7-BD3C0026B95664AE 2017-10-20T00:49:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AD2AA884-B0FC-11E6-B3440026B95664AE 2016-11-23T02:45:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/ADE790E6-E4A1-11E5-BBA20026B95664AE 2016-03-22T01:14:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/ADF9BBB0-0544-11E8-BD3C0026B95664AE 2018-02-10T00:35:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AE153116-1DFB-11E6-BBA20026B95664AE 2016-05-21T00:33:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-question-and-answer-session 2018-12-07T19:50:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AF0C19F6-E631-11E5-BBA20026B95664AE 2016-03-10T01:02:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/AF8941C4-1176-11E6-BBA20026B95664AE 2016-05-04T18:33:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B0480765-E4A7-11E5-BBA20026B95664AE 2016-03-18T00:51:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B180D23E-EAB4-11E4-8F860026B95664AE 2015-04-24T23:14:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B1AD6EA3-E5A4-11E7-BD3C0026B95664AE 2017-12-22T23:35:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B24A3730-B50D-11E7-BD3C0026B95664AE 2017-10-20T00:44:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B28345EE-FB3A-11E4-8F860026B95664AE 2015-05-15T23:45:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B373E8C0-E5A2-11E7-BD3C0026B95664AE 2017-12-20T21:45:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B3F8844E-DA77-11E5-BBA20026B95664AE 2016-05-24T07:49:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4493 2013-01-30T21:26:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B623A59E-0542-11E8-BD3C0026B95664AE 2018-01-30T03:22:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-approaches-for-extending-progression-free-survival-pfs-and-symptom-management-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-pannet1 2018-11-17T01:57:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4737 2013-05-09T01:10:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B71FADCE-9F9C-11E6-B3440026B95664AE 2016-11-01T00:29:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B7780460-2113-11E6-BBA20026B95664AE 2016-05-24T01:03:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B7E8643E-7E42-11E5-BEAE0026B95664AE 2015-10-29T17:46:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B8847A4E-1DFD-11E6-BBA20026B95664AE 2016-05-21T00:36:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B8F69260-DA64-11E5-BBA20026B95664AE 2016-05-24T08:11:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B957EB8E-07DA-11E5-8F860026B95664AE 2015-06-01T04:19:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B958FB83-7F17-11E5-BEAE0026B95664AE 2015-10-30T19:08:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/B99289EE-0DCF-11E8-85EC0026B95664AE 2018-02-10T00:36:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/dual-cgm-and-ketone-monitoring-across-diabetes-care-spectrum 2025-09-08T22:53:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BA5B5746-4C90-11E8-A96B0026B95664AE 2018-04-30T20:09:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/real-world-implications-of-oral-versus-iv-iron-repletion-what-do-the-latest-clinical-trials-teach-us-how-do-they-guide-us 2018-11-21T01:29:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-clinical-case-study-discordant-nipt-and-fetal-gender-by-ultrasound-peter-benn-phd 2018-11-17T01:37:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BBEC42B2-FB3C-11E4-8F860026B95664AE 2015-05-15T23:59:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/introduction-the-changing-paradigm-for-prenatal-screening-for-fetal-aneuploidy-peter-benn-phd 2018-11-16T22:45:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BCEC1A86-8A1E-11E5-BEAE0026B95664AE 2015-11-17T03:33:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BD1951D6-E630-11E5-BBA20026B95664AE 2016-03-10T00:56:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BD6FB800-DB20-11E5-BBA20026B95664AE 2016-03-07T21:48:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BE34163A-6921-11E5-BEAE0026B95664AE 2015-10-14T21:37:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BE603053-FB39-11E4-8F860026B95664AE 2015-05-15T23:38:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/next-generation-sequencing-approaches-to-understanding-the-genetic-basis-of-cancers-for-personalized-medicine-maria-li-lung-phd 2018-11-21T01:27:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/nontuberculous-mycobacteria-a-case-based-guideline-driven-approach-to-care 2020-11-12T02:09:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/BFCEC890-DB1E-11E5-BBA20026B95664AE 2016-03-22T01:17:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C0190C40-D526-11E7-BD3C0026B95664AE 2017-11-29T22:03:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/all-basal-insulins-are-not-created-equal-comparative-pk/pd-efficacy-side-effect-hypoglycemia-and-safety-profiles-for-established-and-new-longer-acting-basal-insulins 2018-11-02T00:00:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/from-evidence-and-data-to-the-front-lines-of-t1dm-management-the-mechanistic-and-therapeutic-rationale-for-dual-sglt1/2-inhibition-in-adults-with-type-1-diabetes 2018-11-21T23:09:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C2061D14-0FA1-11E5-8F860026B95664AE 2015-06-10T22:53:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc 2018-12-07T19:49:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc 2018-12-07T19:49:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc6 2019-02-12T01:28:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C4593933-1DFA-11E6-BBA20026B95664AE 2016-05-21T00:32:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C49E16CA-6916-11E5-BEAE0026B95664AE 2015-10-14T21:41:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C4ADE058-2DFF-11E8-85EC0026B95664AE 2018-03-22T22:36:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C4FD6E5A-3C8C-11E6-BBA20026B95664AE 2016-06-27T21:32:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C56540F6-6922-11E5-BEAE0026B95664AE 2015-10-14T21:32:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C5CA5E97-FB35-11E4-8F860026B95664AE 2015-05-15T23:11:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-results-of-new-mac-lung-focused-trials-evaluating-quality-of-life-qol-bronchiectasis-improvements-ttp-and-microbial-conversion-metrics-to-optimize-antimicrobial-drug-selection 2025-09-30T21:35:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C6C12118-7F6C-11E6-B3440026B95664AE 2016-09-21T00:02:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-of-genomic-profiling-to-optimize-clinical-outcomes-in-patients-with-breast-cancer-rebecca-dent-md-frcp-canada 2018-11-21T03:19:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/C96F2846-1DFF-11E6-BBA20026B95664AE 2016-06-23T00:47:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-015064-ada-cgm-symposium-gavinv2-mp4 2021-07-23T21:31:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CACF542E-7E40-11E5-BEAE0026B95664AE 2015-10-29T17:31:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/translating-guidelines-meta-analysis-and-real-world-trials-to-guide-practical-aspects-of-diabetes-care-in-the-managed-care/hmo-setting-richard-bergenstal-md 2021-05-27T21:17:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CB059316-4C8D-11E8-A96B0026B95664AE 2018-04-30T20:06:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/4041 2012-10-18T22:09:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-to-identify-and-treat-t2d-patients-with-documented-postprandial-hyperglycemia-ppg-pablo-f-mora-md-msc-face-cde 2018-11-08T19:11:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CC365B06-D525-11E7-BD3C0026B95664AE 2017-12-01T19:28:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CDD41380-20DC-11E5-BEAE0026B95664AE 2015-07-06T17:56:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CE55D473-CE26-11E7-BD3C0026B95664AE 2017-11-21T00:21:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/therapeutic-advances-in-atopic-dermatitis-mark-lebwohl-md-program-co-chair 2018-11-09T22:12:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CECB074E-DB10-11E5-BBA20026B95664AE 2016-05-24T07:31:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/basal-insulin-interactive-ars-case-management-session-1-applying-updated-ada/easd-guidelines-to-an-early-onset-patient-with-t2d 2018-11-01T23:57:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CF8605FE-7E62-11E5-BEAE0026B95664AE 2015-10-29T21:33:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/ars-based-interactive-session-focused-on-patient-with-t2d-who-is-on-an-oral-agent-plus-basal-insulin-and-has-suboptimal-control-of-total-ha1c-level-and-who-has-evidence-of-ppg 2018-11-21T23:20:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/CFEE7F8E-8731-11E6-B3440026B95664AE 2016-09-30T21:19:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D05735DF-B510-11E7-BD3C0026B95664AE 2017-10-20T01:03:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D0660466-B0FD-11E6-B3440026B95664AE 2016-11-23T02:54:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D0DFABFE-3982-11E6-BBA20026B95664AE 2016-06-24T00:44:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D13848B0-DB0E-11E5-BBA20026B95664AE 2016-03-07T21:36:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-diabetes 2018-11-08T21:34:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4492 2013-09-26T21:54:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D3C2A87E-3952-11E6-BBA20026B95664AE 2016-06-23T19:02:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D3E91C82-AB72-11E6-B3440026B95664AE 2016-11-16T01:38:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D55F0B9D-3C8D-11E6-BBA20026B95664AE 2016-06-27T21:40:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interact-with-the-experts-real-world-management-of-heart-failure-foundational-role-of-iron-status-and-ida 2018-11-14T22:12:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D5A3D076-DB1F-11E5-BBA20026B95664AE 2016-02-24T22:56:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-insulin-combinations-for-whom-why-when-the-rationale-effectiveness-and-safety-of-fixed-ratio-single-injection-regimens-combining-a-short-acting-glp-1-ra-and-basal-insulin 2018-11-21T23:23:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D63684A8-2C37-11E7-9DF30026B95664AE 2017-04-28T21:27:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D6525FAE-1174-11E6-BBA20026B95664AE 2016-05-04T18:36:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D6EB602D-F4E7-11E4-8F860026B95664AE 2015-05-07T22:36:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D6FBEFCE-0F9F-11E5-8F860026B95664AE 2015-06-10T22:40:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D7C2E522-3980-11E6-BBA20026B95664AE 2016-06-24T00:29:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D80C41B2-7F72-11E6-B3440026B95664AE 2016-09-21T00:48:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D854B846-7E5C-11E5-BEAE0026B95664AE 2015-10-29T23:01:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D8C7038D-8730-11E6-B3440026B95664AE 2016-09-30T21:12:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D9471821-3954-11E6-BBA20026B95664AE 2016-06-23T19:15:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/identifying-appropriate-diabetic-patients-for-deployment-of-fixed-ratio-combination-insulin-glp-1-ra-regimens-an-evidence-based-roadmap-to-comprehensive-glycemic-and-metabolic-control-in-the-patient-with-t2d 2018-11-21T20:19:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/D9C6DEDE-B511-11E7-BD3C0026B95664AE 2017-10-20T01:12:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DA0F6AC6-0F72-11E5-8F860026B95664AE 2015-06-10T21:40:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DB169D5E-E4A4-11E5-BBA20026B95664AE 2016-03-18T00:53:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DB5B67E0-DE9A-11E7-BD3C0026B95664AE 2017-12-11T22:45:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DB609DF0-2E00-11E8-85EC0026B95664AE 2018-03-22T22:46:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DB65F250-07D8-11E5-8F860026B95664AE 2015-06-01T04:18:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/clinical-case-studies-and-case-management-discussions-applying-science-guidelines-and-landmark-trial-based-evidence-to-the-front-lines-of-pancreatic-cancer-practice 2018-11-16T21:07:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/age-related-macular-degeneration-amd-a-case-study-based-overview-of-current-blindness-prevention-treatment-strategies-and-the-necessity-of-prompt-referral-to-a-retina-specialist 2021-03-03T19:37:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DC2BA140-3400-11E6-BBA20026B95664AE 2016-06-23T17:37:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DC2D5D46-B0F7-11E6-B3440026B95664AE 2016-11-23T02:13:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-discussion-and-dialogue 2018-11-21T01:30:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DD66450A-F4E6-11E4-8F860026B95664AE 2015-06-11T00:18:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/focus-on-prevention-of-dme-related-blindness-in-persons-with-diabetes-br-sub-the-role-of-early-screening-and-the-evidence-for-time-sensitive-anti-vegf-therapy-for-preventing-progression-of-diabetic-eye-disease/sub 2021-06-17T23:23:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/DE8AEE8E-3951-11E6-BBA20026B95664AE 2016-06-23T18:52:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/therapeutic-advances-in-atopic-dermatitis 2018-11-21T19:31:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-5075 2014-01-08T21:11:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E12D8EBE-5F15-11E6-B3440026B95664AE 2016-08-10T20:23:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E135267C-CE28-11E7-BD3C0026B95664AE 2017-11-21T00:29:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-optometrist-s-role-in-preventing-diabetes-related-blindness-a-practical-roadmap-for-diagnosis-referral-and-management-of-diabetic-retinopathy-the-foundational-role-of-anti-vegf-therapy 2021-03-30T18:20:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E188DAD0-1DFE-11E6-BBA20026B95664AE 2016-05-21T00:36:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-evidence-for-sensor-based-glucose-monitoring-to-optimize-glycemic-patient-health-and-safety-outcomes-in-persons-with-type-2-diabetes 2021-06-22T21:49:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E2C14796-DB12-11E5-BBA20026B95664AE 2016-03-22T01:20:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4743 2013-05-09T01:12:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E3538118-1483-11E5-8F860026B95664AE 2015-06-17T04:02:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E36F7510-DA66-11E5-BBA20026B95664AE 2016-05-24T07:28:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-cgm-metrics-tir-gmi-and-agps-to-persons-with-diabetes-on-oral-antidiabetic-drugs-oads-using-cgm-to-optimize-health-metrics-and-overall-management-of-diabetes-in-persons-on-oral-medications 2021-02-25T00:50:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E3D93C46-1AAC-11E5-BEAE0026B95664AE 2015-06-26T23:06:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E47AE626-3401-11E6-BBA20026B95664AE 2016-06-23T17:34:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E4A58296-365D-11E7-9DF30026B95664AE 2017-05-11T19:33:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E4C27186-4C90-11E8-A96B0026B95664AE 2018-04-30T20:11:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-strategies-guidelines-and-therapeutic-advances-for-the-comprehensive-continuum-of-metastatic-pancreatic-cancer 2018-11-21T02:57:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-clinical-case-study-cffdna-case-michael-s-ruma-md-mph 2018-11-17T02:06:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E68F155C-2DFE-11E8-85EC0026B95664AE 2018-03-22T22:34:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E6ECD256-6923-11E5-BEAE0026B95664AE 2015-10-14T21:25:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E6EFFE20-7E41-11E5-BEAE0026B95664AE 2015-10-29T17:38:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E6FCAEB6-DB0F-11E5-BBA20026B95664AE 2016-02-24T21:03:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E6FFFC56-1485-11E5-8F860026B95664AE 2015-06-17T04:16:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E73A3D4E-9FA6-11E6-B3440026B95664AE 2016-11-01T00:46:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E7699A60-5E6E-11E6-B3440026B95664AE 2016-08-10T21:27:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E85434BE-6CF8-11E5-BEAE0026B95664AE 2015-10-14T18:52:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/a-review-of-landmark-clinical-trials-in-atopic-dermatitis-how-will-the-data-change-our-approach-to-treating-atopic-dermatitis 2018-11-21T19:30:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/E9406466-B0FB-11E6-B3440026B95664AE 2016-11-23T02:41:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-evidence-based-and-guideline-supported-role-for-nanoliposomal-topoisomerase-inhibitors-in-metastatic-pancreatic-adenocarcinoma2 2018-11-21T04:05:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EA160816-3953-11E6-BBA20026B95664AE 2016-06-23T19:08:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EAC2C8CE-1B6C-11E5-BEAE0026B95664AE 2015-06-26T23:07:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/new-strategies-guidelines-and-therapeutic-advances-for-the-comprehensive-continuum-of-metastatic-pancreatic-cancers 2018-11-16T19:33:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-role-and-application-of-ngs-diagnostic-reports-to-guide-immunotherapy-based-interventions-in-gastric-cancer-and-cholangiosarcoma 2019-05-02T22:54:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EB5085B6-1B73-11E5-BEAE0026B95664AE 2015-06-26T22:54:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EB8A035E-E5A3-11E7-BD3C0026B95664AE 2017-12-20T21:45:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-science-guidelines-and-landmark-trial-based-evidence-to-the-front-lines-of-metastatic-pancreatic-adenocarcinoma 2018-11-17T01:58:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EBBF35B0-07DA-11E5-8F860026B95664AE 2015-06-01T22:27:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/ED0FF1F0-AB74-11E6-B3440026B95664AE 2016-11-16T03:21:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interpretation-of-sensor-based-glucose-metrics-time-in-range-tir-and-ambulatory-glucose-profiles-agp-moduleandnbsp-3-act 2020-12-03T18:37:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/interactive-dialogue-discussion-and-qanda-session-1-focus-on-interpretation-of-new-nccn-guidelines-for-metastatic-pancreatic-adenocarcinoma-role-timing-evidence-mechanistic-implications 2018-11-12T23:17:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EE3E3131-7E43-11E5-BEAE0026B95664AE 2015-10-29T17:51:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/prospective-observational-studies-evaluating-glycemic-metrics-in-persons-with-type-2-diabetes 2021-05-27T21:30:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-foundational-role-of-cgm-for-outcome-optimizing-behavioral-and-lifestyle-based-interventions1 2025-05-14T20:12:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/EFE9B856-A8CA-11E5-BEAE0026B95664AE 2015-12-22T21:50:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-evidence-based-and-guideline-supported-role-for-nanoliposomal-topoisomerase-inhibitors-in-metastatic-pancreatic-adenocarcinoma 2018-11-16T20:35:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F117D0CE-2C38-11E7-9DF30026B95664AE 2017-04-28T21:35:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F1448B8E-0DD0-11E8-85EC0026B95664AE 2018-02-10T00:41:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F1DCC454-4E44-11E8-A96B0026B95664AE 2018-05-03T00:11:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F2230866-0543-11E8-BD3C0026B95664AE 2018-01-30T03:31:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F2C8D590-DB21-11E5-BBA20026B95664AE 2016-05-24T07:34:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F46C6D5E-897E-11E6-B3440026B95664AE 2016-10-03T19:36:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F471A066-DB1D-11E5-BBA20026B95664AE 2016-03-07T21:28:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F597B836-E702-11E5-BBA20026B95664AE 2016-03-18T00:48:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F6141D63-DE9B-11E7-BD3C0026B95664AE 2017-12-13T21:28:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F638D75E-FB3B-11E4-8F860026B95664AE 2015-05-15T23:54:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F69FB3FE-CE26-11E7-BD3C0026B95664AE 2017-11-21T00:15:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F6CA6148-3C74-11E6-BBA20026B95664AE 2016-06-27T18:41:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/evolving-pathogenic-concepts-on-atopic-dermatitis-ad-and-its-systemic-nature-with-implications-for-targeted-therapeutics 2018-11-21T19:32:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F72F3CF8-9872-11E5-BEAE0026B95664AE 2015-12-02T02:45:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F838EDE5-3C8B-11E6-BBA20026B95664AE 2016-06-27T21:27:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F8425016-DB20-11E5-BBA20026B95664AE 2016-02-24T23:05:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/applying-new-trial-based-evidence-guidelines-and-individualized-approaches-to-real-world-management-for-mac-lung-disease1 2025-09-30T21:35:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/F9394520-DB1E-11E5-BBA20026B95664AE 2016-05-24T07:31:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evolving-role-of-integrated-continuous-glucose-monitoring-technology-icgm-in-persons-with-type-1-diabetes-an-evidence-based-roadmap-for-deploying-icgm-to-optimize-glucose-metrics 2021-02-25T00:46:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FB450EF6-7E3D-11E5-BEAE0026B95664AE 2015-10-29T17:10:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-mandate-and-necessity-for-pan-glycemic-control-in-t2d-focus-on-both-fpg-and-postprandial-hyperglycemia-ppg-to-improve-ha1c-target-goal-attainment 2018-11-21T21:33:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/cmr-4907 2013-09-05T22:20:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/the-evidence-for-evaluating-cardiac-patients-with-heart-failure-for-the-presence-of-iron-deficiency-and-iron-deficiency-anemia 2018-11-14T22:04:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FBF89FCE-3E11-11E6-BBA20026B95664AE 2016-06-30T19:55:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/beyond-cgm-dual-sensing-technology-as-a-cornerstone-of-dka-prevention 2026-03-09T20:52:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FCB1DFB0-1B74-11E5-BEAE0026B95664AE 2015-06-26T22:58:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FCDAB86A-7E64-11E5-BEAE0026B95664AE 2015-10-30T17:42:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/questions-and-answers 2018-11-21T04:07:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/copy-cmr-40401 2013-04-24T00:39:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FE5ECB9E-1175-11E6-BBA20026B95664AE 2016-05-04T18:34:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FEDD67B4-E616-11E5-BBA20026B95664AE 2016-03-09T21:56:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/videos/advancing-the-treatment-paradigm-for-ad-focus-on-the-results-and-implications-of-landmark-clinical-trials-evaluating-the-safety-and-efficacy-of-biologic-based-therapy-for-atopic-dermatitis-eric-simpson-md-program-co-chair 2018-11-09T22:26:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/FFFF11F6-B510-11E7-BD3C0026B95664AE 2017-10-20T01:06:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evolving-science-and-medicine-of-cardioprotection-in-type-2-diabetes 2018-04-16T23:36:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evolving-physiologic-basis-for-optimizing-ha1c-target-goal-attainment-in-t2d 2018-11-21T21:14:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/applying-updated-ada/easd-guidelines-to-a-high-risk-vulnerable-patient-with-t2d-who-has-not-achieved-target-ha1c-levels-after-metformin-and-an-sglt-2-inhibitor 2018-11-21T21:10:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-strategies-for-ldl-mediated-cv-risk-reduction-in-high-risk-and-statin-intolerant-patients-requiring-ldl-reduction-clinical-case-study 2018-11-15T05:09:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-strategies-for-ldl-mediated-cv-risk-reduction-in-vulnerable-diabetic-patients-which-agents-in-what-sequence-in-which-patient-subsets-a-case-based-roadmap-to-clinical-success-with-statins-pcsk9-inhibitors-and-related-therapies 2018-11-15T05:15:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-current-therapeutic-landscape-for-cv-risk-reduction-in-patients-with-hypercholesterolemia 2018-11-15T05:14:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/beyond-the-statin-centric-paradigm-for-cv-risk-reduction 2018-11-21T18:32:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-dialogue-session 2018-11-15T05:15:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/novel-mechanisms-and-advancing-paradigms-for-ldl-reduction 2018-11-15T05:01:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-question-and-answer-session-faculty-panel 2018-11-21T20:55:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/what-the-cardiologist-needs-to-know-about-oral-versus-iv-iron-repletion-indications-triggers-and-practical-approaches-for-ensuring-safe-effective-and-predictable-iv-iron-repletion-in-the-cardiovascular-setting 2018-11-21T20:53:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interact-with-the-experts-real-world-management-of-heart-failure 2018-11-21T20:54:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-foundational-role-of-iv-iron-repletion-for-patients-with-heart-failure-what-have-clinical-trials-where-does-the-evidence-lead-us 2018-11-21T20:52:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evidence-for-evaluating-cardiac-patients-with-heart-failure-for-the-presence-of-iron-deficiency-and-iron-deficiency-anemia 2018-11-21T20:51:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-relationship-between-iron-deficiency/iron-deficiency-anemia-and-functional-outcomes-in-patients-with-heart-failure 2018-11-21T20:51:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/evolving-pathogenic-concepts-on-atopic-dermatitis-ad-and-its-systemic-nature-with-implications-for-targeted-therapeutics-professor-emma-guttman-md-phd-program-chair 2018-11-21T04:22:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evolving-and-complex-landscape-of-detecting-assessing-and-managing-iron-deficiency-anemia-in-the-oncology-and-hematology-specialty-setting 2018-11-21T02:30:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evidence-based-journey-from-targets-to-therapy-comprehensive-genomic-profling-to-optimize-precision-focused-cancer-management 2018-11-21T20:46:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/applying-ngs-and-actionable-genomic-alterations-to-patients-with-lung-cancer-professor-peled 2018-11-21T20:42:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-comprehensive-care-and-referral-strategies-for-the-optometrist-webcast 2018-11-21T01:35:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/novel-radiotherapeutic-focused-strategies-for-targeting-deployment-of-ssas-in-patients-with-advanced-and-metastatic-gep-nets-the-role-and-rationale-for-use-of-technology-focused-strategies-such-as-prrt-as-part-of-multimodal-management-s 2018-11-21T20:47:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-decision-making-for-gastrointestinal-neuroendocrine-tumors-nets-translating-disease-type-progression-profiles-biomarkers-and-the-safety-efficacy-equation-for-available-therapies-into-optimal-clinical-management1 2018-11-21T20:46:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-therapeutics-for-extending-progression-free-survival-in-patients-with-gi-nets-focus-on-timing-sequencing-and-regimen-initiation-and-maintenance-for-antiproliferative-ssa-and-chemotherapeutic-interventions1 2018-11-21T20:48:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/focus-on-the-evolving-evidence-based-role-of-novel-therapies-and-technologies-for-prolongation-of-progression-free-survival-in-patients-with-gastrointestinal-nets 2018-11-21T20:50:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/selection-and-timing-of-initial-foundational-therapy-for-gastrointestinal-neuroendocrine-tumors-nets-critical-issues-for-treatment-initiation-and-subsequent-management-of-the-complex-patient-what-does-the-evidence-show 2018-11-21T20:47:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-strategies-and-practice-advances-for-the-comprehensive-continuum-of-gastrointestinal-neuroendocrine-tumors-nets-what-do-we-know-what-do-we-still-need-to-know1 2018-11-21T20:45:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/science-and-evidence-into-gi-oncology-net-focused-practice 2018-11-21T20:49:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-dialogue-discussion-and-qanda-session-1-focus-on-interpretation-of-new-nccn-guidelines-for-metastatic-pancreatic-adenocarcinoma-role-timing-evidence-mechanistic-implications 2018-11-15T00:34:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/therapeutic-advances-in-metastatic-pancreatic-adenocarcinoma-webcast 2018-12-18T19:21:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-treatment-landscape-in-evolution-new-strategies-guidelines-and-therapeutic-advances-for-metastatic-pancreatic-adenocarcinoma-what-do-we-know-what-do-we-still-need-to-know-what-are-the-unmet-needs-in-advanced-disease 2018-11-14T22:55:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/advancing-the-treatment-frontiers-for-metastatic-pancreatic-adenocarcinoma-focus-on-molecular-markers-new-precision-based-technologies 2018-11-14T22:46:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-approaches-for-extending-progression-free-survival-pfs-and-symptom-management-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors-pannet 2018-11-14T22:45:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-landmark-trial-based-evidence-to-the-front-lines-of-care-for-pancreatic-cancer-the-evolving-trial-based-and-guideline-supported-role-for-nanoliposomal-topoisomerase-inhibitors-in-metastatic-pancreatic-adenocarcinoma 2018-11-15T00:27:33+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/clinical-case-studies-and-ars-mediated-case-management-discussions-applying-science-guidelines-and-landmark-trial-based-evidence 2018-11-14T22:41:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optometry-based-blindness-prevention-in-patients-with-dme-and-amd-webcast 2018-11-21T01:48:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-changing-paradigm-for-prenatal-screening-for-fetal-aneuploidy 2018-11-21T20:49:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-clinical-case-study-discordant-nipt-and-fetal-gender-by-ultrasound-peter-benn-phd 2018-11-21T20:47:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-strategies-and-practice-advances-for-the-comprehensive-continuum-of-gastrointestinal-neuroendocrine-tumors-nets-what-do-we-know-what-do-we-still-need-to-know 2018-11-21T20:51:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/clinical-case-studies-and-case-management-discussions-science-and-evidence-into-gi-oncology-net-focused-practice-gep-nets-case-management-sessions-audience-response-system-ars-interactive-analysis-of-patients-nets 2018-11-21T21:05:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-therapeutics-for-extending-progression-free-survival-in-patients-with-gi-nets-focus-on-timing-sequencing-and-regimen-initiation-and-maintenance-for-antiproliferative-ssa-and-chemotherapeutic-interventions 2018-11-21T21:04:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-discussion-and-dialogue-case-studies-on-novel-mechanisims-and-advancing-therapeutic-paradigms-for-optimizing-real-world-management-of-hypercholesterolemia 2018-11-21T21:06:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/real-world-decision-making-for-gastrointestinal-neuroendocrine-tumors-nets-translating-disease-type-progression-profiles-biomarkers-and-the-safety-efficacy-equation-for-available-therapies-into-optimal-clinical-management 2018-11-21T20:52:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/novel-radiotherapeutic-focused-strategies-for-targeting-deployment-of-ssas-in-patients-with-advanced-and-metastatic-gep-nets-the-role-and-rationale-for-use-of-technology-focused-strategies-such-as-prrt-as-part-of-multimodal-management-s1 2018-11-21T21:04:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/selection-and-timing-of-initial-foundational-therapy-for-gastrointestinal-neuroendocrine-tumors-nets 2018-11-21T21:03:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-the-safety-efficacy-equation-for-comprehensive-glycemic-regulation-in-complex-patients-with-t2d-the-physiologic-rationale-for-complementary-pharmacologic-approaches-based-on-insulin-plus-incretin-system-targeting-agents 2018-11-21T23:19:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-type-2-diabetes-focus-on-insulin-based-management-of-t2d 2018-11-02T20:37:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/basal-insulin-interactive-ars-case-management-session-1-applying-updated-ada/easd-guidelines-to-an-early-onset-patient-with-t2d 2018-11-02T18:55:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-physiologic-rationale-for-optimizing-ha1c-target-goal-attainment-with-basal-insulin 2018-11-02T18:58:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/didactic-presentation-including-real-time-video-demonstration-modifying-insulin-therapy-in-complex-and-vulnerable-patients-practical-approaches-for-switching-to-a-physiologic-basal-insulin-formulation 2018-11-02T19:54:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/basal-insulin-interactive-ars-case-management-session-2-optimizing-glycemic-control-in-the-older-or-elderly-patient-with-t2d-at-risk-for-hypoglycemia 2018-11-02T19:34:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/program-chair-summary-the-current-and-future-roadmap-to-optimizing-glycemic-control-in-t2d-with-physiologic-long-acting-basal-insulin-the-evidence-guideline-and-mechanistic-rationale-for-long-acting-physiologic-basal-insulin 2018-11-02T20:32:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-glycemic-control-while-mitigating-hypoglycemic-risk-in-challenging-patients-with-t2d 2018-11-02T18:57:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/basal-insulin-interactive-ars-case-mangemement-session-3 2018-11-02T20:01:51+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/all-basal-insulins-are-not-created-equal-comparative-pk/pd-efficacy-side-effect-hypoglycemia-and-safety-profiles-for-established-and-new-longer-acting-basal-insulins 2018-11-02T19:23:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/comprehensive-care-and-referral-strategies-for-the-optometrist-webcast 2018-11-21T03:04:57+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/what-do-recent-landmark-cardiovascular-outcome-trials-evaluating-pcsk9-inhibition-in-high-risk-patient-populations-teach-us 2018-12-12T18:15:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/getting-real-world-and-hands-on-in-patients-with-elevated-ldl-c-and-high-risk-features-for-atherosclerotic-cardiovascular-disease-interactive-case-management-sessions 2018-12-18T19:21:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/guidelines-and-the-role-of-non-statin-therapies-for-ascvd-reduction-in-high-risk-patients-addressing-statin-intolerance-and-poor-target-ldl-c-goal-attainment 2018-12-12T18:14:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-mandate-for-improving-residual-cardiovascular-disease-risk-reduction-in-patients-with-adversely-elevated-ldl-c 2018-12-12T18:14:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-ars-case-management-and-dialogue-sessions-focused-on-patient-case-management 2018-11-21T23:24:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-survival-and-clinical-outcomes-in-metastatic-cscc 2018-11-21T23:23:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/expanding-the-immunotherapeutic-toolkit-for-late-stage-skin-cancer 2018-11-21T23:21:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/which-patients-with-advanced-cscc-will-likely-benefit-most-from-pd1-checkpoint-inhibition 2018-11-21T23:25:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-pathoimmunobiology-and-translational-implications-of-targeting-the-pd-1-checkpoint-in-metastatic-cutaneous-squamous-cell-carcinoma-cscc 2018-11-21T23:21:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-strategies-guidelines-and-therapeutic-advances-for-the-comprehensive-continuum-of-metastatic-pancreatic-cancer 2018-11-21T03:59:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-strategies-guidelines-and-therapeutic-advances-for-the-comprehensive-continuum-of-metastatic-pancreatic-cancers1 2018-11-21T00:29:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-ha1c-target-goal-attainment-basal-insulin-in-vulnerable-patients-with-type-2-diabetes-webcast 2018-11-21T21:33:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-strategies-guidelines-and-therapeutic-advances-for-the-comprehensive-continuum-of-metastatic-pancreatic-cancers 2018-11-21T00:32:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/basal-insulin-as-a-foundational-strategy-in-t2d 2019-10-11T18:39:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/welcome-and-introduction-program-chair-the-physiologic-basis-and-practical-rationale-for-fixed-ratio-insulin-glp-1-ra-combinations 2019-10-11T18:42:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-guideline-sanctioned-interventions-for-pancreatic-cancer-applying-the-best-practice-roadmap-of-recent-nccn-guidelines-to-optimize-survival-extension-in-metastatic-pancreatic-adenocarcinoma 2018-11-13T01:50:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-treatment-landscape-in-evolution-new-strategies-guidelines-and-therapeutic-advances-for-metastatic-pancreatic-adenocarcinoma 2018-11-21T00:31:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-diabetes 2018-11-09T03:14:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-mandate-for-improving-residual-cvd-risk-reduction-in-diabetic-patients-what-unmet-needs-still-exist-among-high-risk-patients-across-the-diabetes-continuum-of-care-what-new-outcome-substantiated-therapies-are-in-our-toolkit 2018-11-21T21:20:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/case-study-and-t2d-clinical-decision-tree-simulation-1-ars-based-interactive-session-focused-on-patient-with-t2d-who-is-on-metformin-and-sglt-2-inhibitor 2018-11-09T03:16:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/welcome-and-introduction-the-efficacy-and-safety-rationale-for-complementary-multi-mechanistic-approaches-in-t2d 2018-11-08T23:27:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-mechanistic-and-guidelines-sanctioned-rationale-for-optimizing-ha1c-target-goal-attainment-with-physiologic-long-acting-basal-insulin 2018-11-21T21:09:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-mandate-to-minimize-hypoglycemic-risk-in-challenging-patients-with-t2d-who-is-vulnerable-and-why-how-can-physiologic-long-acting-basal-insulin 2018-11-21T21:09:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/addressing-the-complex-metabolic-safety-efficacy-and-compliance-and-ha1c-target-needs-of-challenging-t2d-patients-managed-in-the-specialty-setting 2018-11-09T02:29:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/year-2018-acc-guideline-update-the-ecdp-report-on-non-statin-therapies-for-ashd-reduction-in-diabetic-patients-addressing-statin-intolerance-poor-target-ldl-goal-attainment-and-resistance-syndromes-in-diabetes-specialty-practice 2018-11-21T21:21:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/overcoming-institutional-cost-and-clinical-inertia-barriers-to-deployment-of-non-statin-therapies-for-optimizing-cv-outcomes-in-diabetes-a-roadmap-to-clinical-success-for-the-diabetes-specialist 2018-11-21T21:23:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-mandate-to-identify-and-treat-t2d-patients-with-documented-postprandial-hyperglycemia-ppg 2018-11-08T23:35:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/what-do-recent-landmark-cardiovascular-outcome-trials-evaluating-pcsk9-inhibition-in-the-diabetic-patient-population-teach-us-how-effective-are-pcsk9-inhibitors-in-the-diabetic-population-overall-how-safe 2018-11-21T21:21:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/case-study-and-t2d-clinical-decision-tree-simulation-ars-based-interactive-session-focused-on-patient-with-t2d 2018-11-09T02:26:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-qanda-session1 2018-11-21T21:24:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/getting-real-world-and-hands-on-in-diabetes-practice 2018-11-21T21:22:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-the-safety-efficacy-equation-in-complex-t2d-patients-with-fixed-ratio-basal-insulin-plus-a-short-acting-glp-1-ra-combination-regimen 2018-11-09T02:19:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/practical-specialty-focused-strategies-for-switching-to-a-physiologic-basal-insulin-formulation 2018-11-21T21:13:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/insulin-differentiation-and-clinical-decision-making-comparative-pk/pd-efficacy-side-effect-hypoglycemia-and-safety-profiles-for-physiologic-long-acting-basal-insulins-an-insulin-centric-roadmap-for-the-diabetes-specialist 2018-11-21T21:11:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/balancing-the-safety-efficacy-equation-in-the-older-vulnerable-patient-with-t2d-at-risk-for-nocturnal-hypoglycemia 2018-11-21T21:12:31+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/complex-patients-who-have-been-on-various-insulin-formulations 2018-11-21T21:13:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/qanda-session-and-special-hot-topics-in-t2d-session-hot-topics-in-type-2-diabetes-focus-on-physiologic-long-acting-insulin-based-management-of-t2d 2018-11-21T21:14:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-qanda-session 2018-11-02T00:20:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/all-long-acting-insulins-are-not-created-equal-how-are-they-similar-how-are-they-critically-different-pablo-f-mora-md-face 2018-11-21T20:39:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/addressing-the-challenges-safety-needs-and-target-goal-considerations-of-complex-and-high-risk-patients-with-diabetes 2018-11-21T20:38:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-practical-roadmap-for-insulin-based-management-switching-selection-and-sustainability-of-long-acting-insulin-formulations 2018-11-21T20:39:56+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-physiologic-and-evidence-basis-for-deploying-long-acting-insulin-formulatings-in-diabetes-specialty-care 2018-11-21T20:40:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/welcome-and-introduction-the-unmet-therapeutic-needs-for-moderate-to-severe-atopic-dermatitis-ad 2018-11-09T23:01:15+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-targets-into-therapy-the-pathoimmunobiology-of-atopic-dermatitis-focus-on-novel-treatments-and-the-role-of-immune-mediated-inflammation-in-ad-emma-guttman-md-phd 2018-11-09T23:13:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/therapeutic-advances-in-atopic-dermatitis-mark-lebwohl-md-program-co-chair 2018-11-09T23:05:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/risk-directed-therapy-for-ad-aligning-the-ad-toolkit-with-patient-specific-disease-severity 2018-11-14T00:14:53+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/advancing-the-treatment-paradigm-for-ad 2018-11-14T00:10:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-dialogue-session-qanda-7155 2018-11-14T00:32:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/unmet-therapeutic-needs-in-adult-patients-with-type-1-diabetes 2018-11-21T23:03:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/immunotherapy-in-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc 2019-10-07T21:41:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/immunotherapy-in-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc-cmr-8936 2018-12-01T04:32:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/immunotherapy-in-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc-8933 2018-12-27T20:43:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/immunotherapy-in-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc-9692 2018-12-27T21:16:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/immunotherapy-in-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc-9691 2018-12-27T21:06:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-immunotherapeutic-options-in-late-stage-skin-cancer 2019-03-26T18:41:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/immunotherapy-in-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc-9965 2019-10-07T21:14:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-clinical-evidence-for-sensor-based-glucose-monitoring-and-technological-innovations-to-the-front-lines-of-clinical-practice 2023-04-14T03:11:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/pd-1-targeting-therapy-inadvanced-andmetastatic-cutaneous-squamous-cell-carcinoma-cscc-009967 2019-03-26T22:46:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/physiologic-basal-insulin-interactive-ars 2018-11-21T20:02:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/physiologic-basal-insulin-interactive-ars1 2018-11-21T20:00:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-current-and-future-roadmap-to-optimizing-basal-insulin-based-glycemic-control-in-t2d 2018-11-21T20:03:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/practical-aspects-of-switching-to-a-physiologic-basal-insulin-formulation 2018-11-21T20:01:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/all-basal-insulins-are-not-created-equal 2018-11-21T20:00:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-glycemic-control-while-mitigating-hypoglycemic-risk-in-t2d 2018-11-21T19:59:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/physiologic-long-acting-basal-insulin-interactive-ars 2018-11-21T19:59:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interactive-qanda-session-and-special-hot-topics-in-t2d-session-faculty-panel 2018-11-21T20:04:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-clinical-evidence-for-sensor-based-glucose-monitoring-and-technological-innovations-to-the-front-lines-of-clinical-practice-010259 2023-04-14T03:11:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/therapeutic-advances-patient-adherence-and-novel-formulations-for-the-treatment-of-mycobacterium-avium-complex-mac-lung-disease-webinar 2023-04-14T03:11:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/nontuberculous-mycobacteria-a-case-based-guideline-driven-approach-to-care-br-focus-on-mac-lung-disease 2023-04-14T02:53:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-clinical-evidence-for-sensor-based-glucose-monitoring-and-technological-innovations-to-the-front-lines-of-clinical-practice-011872 2023-04-14T03:12:11+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-clinical-evidence-for-sensor-based-glucose-monitoring-and-technological-innovations-to-the-front-lines-of-clinical-practice-011875 2023-04-14T03:12:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/interpretation-of-sensor-based-glucose-metrics-time-in-range-tir-and-ambulatory-glucose-profiles-agp-011878 2023-04-14T02:50:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-clinical-evidence-for-sensor-based-glucose-monitoring-and-technological-innovations-to-the-front-lines-of-clinical-practice-011878 2024-06-22T17:38:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/understanding-the-year-2020-ats/ers/escmid/idsa-guidelines-applying-evidence-based-guidelines-to-the-front-lines-of-mac-lung-disease-management 2023-04-14T03:17:41+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-diabetes-and-primary-care-specialist-s-perspective-on-prevention-of-inevitable-blindness-in-the-patient-with-diabetes-focus-on-the-importance-of-prompt-referral 2023-04-14T02:59:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-optometrist-s-critical-role-in-screening-diagnosis-and-referring-patients-with-diabetic-retinopathy-focus-on-the-importance-of-prompt-referral-to-a-retina-specialist-for-definitive-management 2023-04-14T03:06:13+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/preventing-inevitable-blindness-in-the-diabetic-patient-focus-on-screening-examinations-detection-risk-stratification-and-prompt-referral-to-retina-specialists-of-individuals-with-diabetic-retinopathy 2023-04-14T02:55:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/preventing-inevitable-blindness-in-the-patient-with-diabetes-optimizing-referral-management-and-treatment-strategies-for-diabetic-macular-edema-dme-guidance-for-prompt-referral-and-the-effectiveness-of-anti-vegf-therapy 2023-04-14T02:56:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/treatment-decisions-for-ntm-pd-an-international-guideline-based-approach-to-optimizing-outcomes-in-mac-lung-disease 2023-04-14T03:16:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/foundational-pathobiological-and-novel-therapeutic-advances-in-non-cystic-fibrosis-bronchiectasis-ncfbe-br-sub-emerging-investigational-evidence-for-neutrophil-directed-oral-therapies-based-on-dpp-1-inhibition-to-reduce-frequency-of-exa 2023-04-14T02:43:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-blindness-prevention-treatment-strategies-for-diabetic-retinopathy-dr-a-case-based-focus-on-screening-and-prompt-referral-to-a-retina-specialist 2023-04-14T02:52:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/applying-cgm-metrics-tir-gmi-and-agps-to-persons-with-diabetes-on-oral-antidiabetic-drugs-oads-using-cgm-to-optimize-health-metrics-and-overall-management-of-diabetes-in-persons-on-oral-medications 2023-04-14T02:33:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evolving-role-of-integrated-continuous-glucose-monitoring-technology-icgm-in-persons-with-type-1-diabetes-an-evidence-based-roadmap-for-deploying-icgm-to-optimize-glucose-metrics 2023-04-14T03:00:54+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-role-of-early-screening-detection-and-referral-of-patients-with-nonproliferative-diabetic-retinopathy-npdr-the-evidence-for-time-sensitive-anti-vegf-therapy-for-preventing-inevitable-blindness-in-persons-with-diabetes 2023-04-14T03:10:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/evolving-strategies-for-proliferative-diabetic-retinopathy-the-role-of-screening-anti-vegf-therapy-and-optometrist-generated-referral-to-a-retinal-specialist-to-maximize-blindness-prevention-in-persons-with-diabetes 2023-04-14T02:42:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/age-related-macular-degeneration-amd-a-case-study-based-overview-of-current-blindness-prevention-treatment-strategies-and-the-necessity-of-prompt-referral-to-a-retina-specialist 2023-04-14T02:32:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-case-based-master-session-on-treatment-of-mac-lung-disease-the-intersection-of-new-ats/idsa-guidelines-and-clinical-decision-making-at-the-front-lines-of-specialty-care 2023-04-14T01:48:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-mandate-for-applying-sensor-based-cgm-at-the-front-lines-of-diabetes-care-focus-on-optimizing-outcomes-in-persons-requiring-insulin-and-combination-insulin-based-treatments-the-role-of-agps-for-refining-therapeutic-interventions 2023-04-14T03:05:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-optometrist-s-role-in-preventing-diabetes-related-blindness-br-sub-a-practical-roadmap-for-diagnosis-referral-and-management-of-diabetic-retinopathy-the-foundational-role-of-anti-vegf-therapy/sub 2023-04-14T03:06:36+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/technological-behavioral-and-practical-aspects-of-real-time-glucose-alarms-on-sensor-based-glucose-monitoring-devices-br-sub-individualizing-to-improve-patient-satisfaction-and-minimize-risks-of-hypo-and-hyperglycemia/sub 2023-04-14T02:59:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/015061cme 2023-04-14T03:16:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/guideline-directed-treatment-strategies-for-non-cystic-fibrosis-bronchiectasis-ncfbe-br-sub-the-foundations-of-risk-stratification-and-exacerbation-management/sub 2023-04-14T22:51:18+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-foundational-role-and-practical-implementation-of-sensor-based-glucose-monitoring-to-optimize-clinical-outcomes-in-persons-with-type-2-diabetes 2023-04-14T03:04:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/evolving-observational-and-real-world-data-around-the-use-of-sensor-based-cgm-across-the-diabetes-treatment-spectrum-br-sub-optimizing-outcomes-in-persons-with-type-2-or-type-1-diabetes/sub 2023-04-14T02:39:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-practical-step-by-step-approach-for-incorporating-sensor-based-cgm-to-optimize-care-in-persons-with-diabetes-br-sub-a-real-world-primer-for-the-nurse-practitioner-np/sub 2023-04-14T02:31:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-trial-based-evidence-and-real-world-data-for-sensor-based-glucose-monitoring-to-optimize-health-metrics-in-persons-across-the-diabetes-spectrum 2023-04-14T03:15:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/critical-advances-in-mitigating-progression-of-diabetic-eye-disease-br-sub-the-role-of-screening-prompt-referral-and-anti-vegf-therapy-to-prevent-vision-loss-associated-with-diabetic-retinopathy-dme-and-amd-across-the-spectrum-of-diabet 2023-04-14T02:35:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/trial-based-evidence-and-real-world-clinical-and-pharmacoeconomic-data-for-cgm-at-the-front-line-of-diabetes-care-in-the-managed-care-setting 2023-04-14T03:17:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-role-of-bronchiectasis-and-copd-as-risk-factors-for-mac-lung-disease-critical-advances-in-disease-stratification-and-recent-international-guidelines-for-antimicrobial-management 2023-04-14T03:10:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/why-use-continuous-glucose-monitoring-to-improve-diabetes-management-in-primary-care 2023-04-14T03:19:12+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/critical-advances-in-flash-based-cgm-a-foundational-approach-to-optimizing-health-metrics-and-costs-across-the-entire-spectrum-of-diabetes-care 2022-03-01T20:03:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/navigating-and-deploying-sensor-based-glucose-monitoring-in-the-managed-care-pharmacy-and-medical-setting 2023-04-14T02:51:38+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/from-clinical-suspicion-and-co-morbid-risk-factors-to-diagnostic-confirmation-of-mac-lung-disease 2023-04-14T02:44:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/translating-current-updated-ats/idsa/ers-guidelines-for-mac-lung-disease-to-the-front-lines-of-specialty-practice 2023-04-14T03:13:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/identifying-persons-with-diabetes-who-will-benefit-from-sensor-based-cgm-br-sub-overcoming-barriers-to-authorization-and-deployment-in-the-managed-care-pharmacy/sub 2022-06-27T17:33:30+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/optimizing-use-of-sensor-based-cgm-in-persons-with-diabetes-what-improvements-in-patient-outcomes-well-being-and-satisfaction-can-you-expect-br-sub-a-case-based-roadmap-to-cgm-deployment-and-optimization-in-the-managed-care-setting/sub 2022-06-27T17:37:59+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-clinical-outcome-and-success-roadmap-for-mac-ld-br-sub-what-outcome-radiological-and-microbiological-parameters-should-be-achieved-and-monitored/sub 2023-04-14T02:27:45+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/established-strategies-and-evolving-approaches-for-ncfbe-br-sub-guideline-based-tactics-and-emerging-novel-therapies-for-managing-bronchiectasis/sub 2023-04-14T02:38:58+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-step-by-step-approach-to-launching-and-maintaining-a-cgm/agp-based-management-program-in-the-primary-care-setting 2022-11-29T20:32:06+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/authorizing-establishing-and-deploying-sensor-based-glycemic-monitoring-in-the-managed-care-pharmacy-setting-br-sub-practical-aspects-of-pharmacy-based-implementation-reimbursement-and-integration-of-cgm-based-care/sub 2023-04-14T02:34:28+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/risk-stratification-and-therapeutic-targeting-for-ncfbe-br-sub-guideline-based-strategies-and-emerging-novel-therapies/sub 2023-04-14T02:59:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/clinical-conversations-on-the-use-of-technology-in-the-primary-care-setting 2023-04-14T02:35:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-foundational-importance-of-cgm/agp-based-management-of-persons-with-t2d-in-the-primary-care-setting-br-sub-what-do-the-studies-and-guidelines-teach-us/sub 2023-04-14T03:01:23+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-foundational-role-and-best-practice-dimensions-of-sensor-based-glycemic-monitoring-in-the-managed-care-setting-br-sub-a-practical-roadmap-for-establishing-and-deploying-cgm-across-the-spectrum-of-diabetes-care/sub 2023-04-14T03:04:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/implications-and-translation-of-recent-technological-advances-in-flash-based-glucose-monitoring-to-the-front-lines-of-diabetes-management 2023-04-14T02:46:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/foundational-and-evolving-approaches-to-multimodal-management-of-non-cystic-fibrosis-bronchiectasis-ncfbe-br-sub-the-role-of-inflammation-vs-infection-in-disease-exacerbation/sub 2023-04-14T02:43:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-rationale-and-evidence-for-initiating-and-monitoring-sensor-based-cgm-to-optimize-care-of-persons-with-diabetes-br-sub-the-pa-s-role-and-practical-action-steps-to-establish-cgm-based-glycemic-management/sub 2023-04-14T03:07:01+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/a-step-by-step-approach-for-launching-and-maintaining-a-cgm/agp-based-diabetes-management-program-in-the-primary-care-setting-br-sub-what-do-i-need-to-know-to-incorporate-cgm/agp-into-my-primary-care-practice/sub 2023-04-14T02:32:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-introductory-fundamentals-of-sensor-based-cgm-a-primary-care-specialist-s-perspective 2023-04-14T03:05:20+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/using-cgm-based-glycemic-management-and-agp-readouts-to-improve-diabetes-management-and-outcomes-for-persons-with-t2d-in-the-primary-care-setting 2023-04-14T03:18:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/incorporating-cgm-based-glucose-pattern-insight-reports-gpir-and-treatment-prompts-to-manage-type-2-diabetes-in-the-primary-care-setting-br-sub-refining-and-simplifying-clinical-decision-making-based-on-cgm/sub 2023-04-14T02:50:03+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/critical-therapeutic-advances-for-optimizing-clinical-outcomes-in-mac-lung-disease-br-sub-focus-on-ers-guideline-directed-use-of-inhaled-antimicrobial-formulations-for-ntm-pulmonary-disease/sub 2023-10-13T01:16:34+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/practical-advances-in-front-line-strategies-for-optimizing-clinical-outcomes-in-mac-lung-disease 2023-09-06T21:20:19+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/practical-easy-to-implement-strategies-for-adopting-sensor-based-cgm-to-optimize-diabetes-care-in-the-family-medicine-setting-br-sub-which-patients-why-how-with-which-technology/sub 2023-04-14T02:53:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/implications-and-translation-of-recent-technological-advances-in-flash-glucose-monitoring-to-the-front-lines-of-diabetes-management 2023-04-14T02:47:22+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/moving-beyond-hba1c-new-monitoring-standards-and-target-destinations-for-optimizing-glycemic-control-with-cgm 2024-05-14T19:08:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-trends-in-reimbursement-protocols-health-quality-metrics-and-device-accuracy-for-sensor-based-glycemic-monitoring-in-the-managed-care-pharmacy-setting-using-different-system 2023-10-11T23:11:35+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/ncfbe-clinical-evaluation-and-diagnosis-disease-management-overview-risk-stratification-and-the-role-of-dpp-1-inhibition-in-managing-exacerbations 2023-04-14T02:52:07+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/implementing-sensor-based-cgm-in-the-managed-care-setting-br-sub-a-managed-care-focused-roadmap-for-authorizing-coding-patient-selection-and-deploying-cgm-across-the-spectrum-of-diabetes-care/sub 2023-04-14T02:46:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/implementing-sensor-based-cgm-in-the-managed-care-setting-br-sub-a-managed-care-focused-roadmap-for-authorizing-coding-patient-selection-and-deploying-cgm-across-the-spectrum-of-diabetes-care-acpe/sub 2023-10-23T21:34:55+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-rationale-and-real-world-evidence-for-adopting-sensor-based-cgm-to-optimize-diabetes-care-in-the-primary-care-setting 2023-04-14T03:07:26+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/current-guidelines-and-recommendations-for-multimodal-management-of-non-cystic-fibrosis-bronchiectasis-br-sub-a-year-2022-2023-review/sub 2023-04-14T02:37:09+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/moving-beyond-hba1c-precise-individualized-sensor-based-glucose-monitoring-to-optimize-health-outcomes-in-persons-with-diabetes 2023-04-14T02:51:10+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/practical-evidence-and-guideline-directed-advances-in-antimicrobial-treatment-for-mac-lung-disease 2023-04-25T22:12:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/the-evolving-and-clinically-actionable-patho-inflammatory-landscape-for-non-cystic-fibrosis-bronchiectasis-ncfbe 2023-04-15T01:18:25+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/diagnosis-evaluation-and-treatment-of-bronchiectasis-br-sub-evolving-strategies-for-managing-exacerbations/sub 2023-04-15T01:19:27+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/bronchiectasis-the-knowns-and-unknowns-and-what-the-future-holds-for-patient-care 2023-04-21T17:38:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/ncfbe-risk-stratification-deteriorating-patients-and-real-world-case-studies 2023-04-21T19:17:08+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/diagnosis-evaluation-and-treatment-of-bronchiectasis-br-sub-focus-on-the-role-of-inflammation-in-driving-disease-burden-and-progression/sub 2023-07-11T22:00:52+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/moving-beyond-hba1c-new-standards-for-assessing-glycemic-control-practical-action-steps-for-establishing-cgm-based-care-at-the-front-lines-of-primary-care-practice 2023-05-19T00:20:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/novel-therapeutic-advances-in-non-cystic-fibrosis-bronchiectasis-ncfbe-br-sub-new-approaches-for-minimizing-exacerbations/sub 2023-10-12T22:40:48+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/inhaled-antimicrobial-therapy-for-mac-lung-disease-br-sub-completing-the-journey-from-diagnosis-to-cure/sub 2023-06-15T00:28:02+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/moving-beyond-hba1c-br/sub-new-standards-and-target-destinations-for-optimizing-glycemic-control-with-cgm/sub 2023-06-21T23:23:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/moving-beyond-hba1c-br-sub-practical-action-steps-for-establishing-cgm-based-care-at-the-front-lines-of-np-practice/sub 2023-06-22T21:51:49+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/ntm-management-don-t-let-it-scare-you-br-sub-completing-the-journey-from-diagnosis-to-cure/sub 2024-04-01T17:50:47+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/moving-beyond-hba1c-new-standards-for-the-family-physician-br-sub-the-evidence-and-role-of-sensor-based-cgm-for-improving-patient-care-and-satisfaction-in-persons-with-type-2-diabetes/sub 2024-05-14T19:03:50+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/cgm-expert-boards-move-beyond-hba1c-to-apply-technology-based-advances-across-the-full-spectrum-of-diabetes-care 2024-02-28T21:53:21+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/cgm-expert-boards-move-beyond-hba1c-to-apply-technology-based-advances-across-the-full-spectrum-of-diabetes-care-031205 2024-06-19T02:21:32+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/early-use-of-cgm-in-type-2-diabetes-br-sub-late-breaking-trials-on-cgm-directed-glycemic-management-patient-safety-and-resource-utilization-across-the-spectrum-of-diabetes-care/sub-031206 2024-06-19T02:21:44+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/early-use-of-cgm-in-type-2-diabetes-br-sub-late-breaking-trials-on-cgm-directed-glycemic-management-patient-safety-and-resource-utilization-across-the-spectrum-of-diabetes-care/sub 2024-09-05T22:04:00+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/cgm-as-an-essential-companion-across-the-full-spectrum-of-diabetes-care-br-sub-cgm-based-improvements-in-lifestyle-management-glycemic-metrics-cv-outcomes-and-mortality/sub 2024-09-05T19:53:43+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/new-trial-based-advances-for-optimizing-outcomes-in-mac-pulmonary-disease 2025-03-17T19:21:04+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/outcome-optimizing-synergies-between-cgm-and-self-management-in-t2d-br-sub-pivotal-advantages-in-patient-engagement-and-improved-glycemic-metrics-in-diabetes/sub 2025-09-26T20:11:40+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/outcome-optimizing-synergies-between-cgm-and-self-management-in-t2d-br-sub-pivotal-advantages-in-patient-engagement-and-improved-glycemic-metrics-in-the-primary-care-setting/sub 2025-09-05T20:40:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/technological-advances-and-the-evolution-of-cgm-based-diabetes-management 2025-09-05T20:40:29+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/best-practice-advances-in-front-line-management-to-optimize-clinical-outcomes-in-br-nontuberculous-mycobacterial-ntm-lung-disease 2026-03-07T01:39:24+0000 weekly 0.8 https://cmr.2.broadcastmed.net/courses/pushing-the-limits-of-what-sensing-can-do-for-t1d-and-t2d 2026-03-09T21:51:39+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/a-practical-step-by-step-approach-for-incorporating-sensor-based-cgm-to-optimize-care-in-persons-with-diabetes 2022-06-21T19:34:05+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/practical-easy-to-implement-strategies-for-adopting-sensor-based-cgm-to-optimize-diabetes-care-in-the-family-medicine-setting-br-sub-which-patients-why-how-with-which-technology/sub 2022-09-12T23:51:46+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/the-rationale-and-real-world-evidence-for-adopting-sensor-based-cgm-to-optimize-diabetes-care-in-the-primary-care-setting 2023-01-05T00:18:42+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/translating-clinical-evidence-for-sensor-based-glucose-monitoring-and-technological-innovations-to-the-front-lines-of-clinical-practice-slide-presentation 2020-06-19T01:56:17+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/the-foundational-role-and-practical-implementation-of-sensor-based-glucose-monitoring-to-optimize-clinical-outcomes-in-persons-with-type-2-diabetes 2022-05-27T22:20:16+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/targeting-diabetic-patients-for-physiologic-long-acting-basal-insulin-powerpoint 2018-11-16T03:10:14+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/implications-and-translation-of-recent-technological-advances-in-flash-glucose-monitoring-to-the-front-lines-of-diabetes-management 2022-09-15T20:26:37+0000 weekly 0.8 https://cmr.2.broadcastmed.net/flexpaper/critical-therapeutic-advances-for-optimizing-clinical-outcomes-in-mac-lung-disease 2022-09-02T01:09:49+0000 weekly 0.8